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ABSTRACT
Artificial intelligence and machine learning have the potential to transform health
care by deriving new and important insights from the vast amount of data gener-
ated during routine delivery of healthcare. The digitization of health data provides
an important opportunity for new knowledge discovery and improved care delivery
through the development of clinical decision support that can leverage this data to
support various aspects of healthcare - from early diagnosis to epidemiology, drug
development, and robotic-assisted surgery. These diverse efforts share the ultimate
goal of improving quality of care and outcome for patients. This thesis aims to tackle
long-standing problems in machine learning and healthcare, such as modeling label
uncertainty (e.g., from ambiguity in diagnosis or poorly labeled examples) and rep-
resentation of data that may not be reliably accessible in a live environment.
Label uncertainty hinges on the fact that even clinical experts may have low
confidence when assigning a medical diagnosis to some patients due to ambiguity in
the case or imperfect reliability of the diagnostic criteria. As a result, some data
used for machine training may be mislabeled, hindering the model’s ability to learn
the complexity of the underlying task and adversely affecting the algorithm’s overall
performance. In this work, I describe a heuristic approach for physicians to quantify
their diagnostic uncertainty. I also propose an implementation of instance-weighted
support vector machines to incorporate this information during model training.
To address the issue of unreliable data, this thesis examines the idea of learning
xii
using “partially available” privileged information. This paradigm, based on knowl-
edge transfer, allows for models to use additional data available during training but
may not be accessible during testing/deployment. This type of data is abundant in
healthcare, where much more information about a patient’s health status is available
in retrospective analysis (e.g., in the training data) but not available in real-time en-
vironments (e.g., in the test set). In this thesis, “privileged information” are features
extracted from chest x-rays (CXRs) using novel feature engineering algorithms and
transfer learning with deep residual networks. This example works well for numerous
clinical applications, since CXRs are retrospectively accessible during model training
but may not be available in a live environment due to delay from ordering, developing,
and processing the request.
This thesis is motivated by improving diagnosis of acute respiratory distress syn-
drome (ARDS), a life-threatening lung injury associated with high mortality. The
diagnosis of ARDS serves as a model for many medical conditions where standard
tests are not routinely available and diagnostic uncertainty is common. While this
thesis focuses on improving diagnosis of ARDS, the proposed learning methods will
generalize across various healthcare settings, allowing for better characterization of
patient health status and improving the overall quality of patient care. This thesis also
includes development of methods for time-series analysis of longitudinal health data,
signal processing techniques for quality assessment, lung segmentation from complex
CXRs, and novel feature extraction algorithm for quantification of pulmonary opacifi-
cation. These algorithms were tested and validated on data obtained from patients at
Michigan Medicine and additional external sources. These studies demonstrate that
careful, principled use of methodologies in machine learning and artificial intelligence
can potentially assist healthcare providers with early detection of ARDS and help





The overarching, long-term goal of my research is to develop the computational
methods needed to help organize, process, and transform patient data into actionable
knowledge, and to work toward using machine learning and data science to build
models that will leverage electronic health records in ways that can help healthcare
providers improve patient outcomes. The research efforts of this thesis has appli-
cations in modeling disease progression and predicting adverse outcomes - including
work on developing approaches that can leverage label uncertainty and partially avail-
able data, with the ultimate goal of improving quality of care for patients.
The digitization of health data provides an important opportunity for new knowl-
edge discovery and improved care delivery through the development of clinical de-
cision support that can leverage this vast data to support all aspects of healthcare.
The advent and accelerated adoption of electronic health records (EHR), as a result
of efforts during the Obama administration [1], facilitated the process of generating
datasets containing electronically-stored medical data - creating a strong platform
digital health innovation. Although EHRs faced significant barriers to adoption [2],
this shift in paradigm positioned healthcare for applications of data-driven analyt-
ics and artificial intelligence (AI) in the future of medicine. These advances are
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expected to enhance the quality of healthcare adminstration, automation, and intelli-
gent decision-making in primary/tertiary patient care and public healthcare systems
for years to come.
Although EHRs came with the promise of faster and more efficient care, providers
in modern settings continue to be inundated by the vast amounts of clinical data
being generated during routine patient care. A seminal report from the Institute
of Medicine [3] describes how inaccurate medical diagnosis remains a frequent and
critical issue for disparity in the quality of healthcare. My research uses machine
learning and methodologies in AI to examine such long-standing problems. Specif-
ically, the works in this thesis investigate mathematical approaches to model label
uncertainty (e.g., from ambiguity in diagnosis or poorly labeled examples) and repre-
sentation of data that may not be reliably accessible in clinical settings (e.g., model
testing/deployment).
Label uncertainty hinges on the fact that even clinical experts may have low con-
fidence when assigning a medical diagnosis to some patients due to ambiguity in the
case or imperfect reliability of the diagnostic criteria. As a result, some data used
for machine training may be mislabeled, hindering the model’s ability to learn the
complexity of the underlying task and adversely affecting the algorithm’s overall per-
formance. Furthermore, substantial electronic health data is currently unused (or
under-used) during design and training of medical prediction systems, because this
data may not be available in live clinical environments. The works presented in this
thesis also examine novel approaches to use this type of data as “privileged infor-
mation” during learning, should improve the accuracy and efficiency of algorithm
training, and allowing the integration of a broader array of health data for precision
diagnosis. Integrating these disparate data sources in real-time and effectively as-
sisting clinicians in medical decisions could potentially transform how patient care is
delivered. By synthesizing this digital information into actionable knowledge, these
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systems have the potential to provide important insights into the health status of
patients, helping physicians make more timely and accurate medical diagnosis and
evidence-based treatment decisions.
To achieve this broad set of goals in my research, I aim to develop theoretically-
motivated, principled algorithms by drawing from probabilistic modeling, learning
using privileged information, reinforcement learning, computer vision, Bayesian in-
ference, and other structured learning approaches. Furthermore, while conducting
the research described in this thesis, I also take into consideration the issues of in-
terpretability, reliability, and trustworthiness from the perspective of a healthcare
provider to ensure that that the algorithms developed in this thesis will consistently
perform as expected, even in the most rigorous tasks. These computational method-
ologies can assist physicians with making a timely, accurate medical diagnosis to
improve quality of care and outcome for patients.
1.2 Background
This thesis is motivated by improving diagnosis of acute respiratory distress syn-
drome (ARDS), a type of critical respiratory failure. The diagnosis of ARDS serves
as a model for many medical conditions where simple, inexpensive gold standard tests
are not routinely available and diagnostic uncertainty is common, even among medi-
cal experts. While the current proposal focuses on improving diagnosis of ARDS, the
proposed learning methods will generalize across various healthcare settings, allowing
for better characterization of patient health status and improving the overall quality
of patient care.
1.2.1 Acute Respiratory Distress Syndrome
ARDS is life-threatening lung injury characterized by poor oxygenation, diffuse
pulmonary infiltrates, and acuity of onset [4]. On the pathological level, this condition
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is associated with widespread edema and buildup of fluids in the lung. As a result,
breathing becomes difficult and organs are deprived of the oxygen needed to function.
The clinical corollary is catastrophic and generally associated with poor outcomes,
with such risks increasing with age and severity of illness [5].
This condition manifests as an acute injury to the lung, commonly resulting from a
prior inciting event such as sepsis, trauma, and severe pulmonary infections [6]. About
50 percent of patients who develop ARDS do so within 24 hours of the inciting event;
at 72 hours, 85 percent of patients have clinically apparent ARDS [7]. The clinical
presentation of ARDS is characterized by dyspnea, profound hypoxemia, decreased
lung compliance, and diffuse bilateral infiltrates on chest radiography.
(a) (b)
Figure 1.1: Chest x-rays depicting unremarkable presentation and ARDS. The findings of
(a) shows a negative diagnosis while (b) is representative of an ARDS diagnosis.
Imaging findings are variable and depend upon the severity of ARDS. The initial
chest radiograph typically depicts diffuse, bilateral alveolar opacities with dependent
atelectasis [8]. Example chest x-ray (CXRs) depicting difference between a normal
presentation and a diagnosis of ARDS is provided in Figure 1.1. The radiographic
appearance of ARDS changes over time, with radiogarphic abnormalities following a
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perceptible sequence to mirror the rapid histopathological changes. In the first 24
hours following insult, mild alveolar edema is typically present on the CXR [9]. As
ARDS progresses, widespread ground-glass opacification becomes more apparent on
CT scans. During the next 36 hours, if the condition continues to worsen, the clinical
course is characterized by further leakage of inflammatory fluid into the interstitium
and air spaces, with evident consolidation on the CXR [10].
ARDS is associated with a high mortality (40% unadjusted mortality, increasing
with condition severity [11]), affecting 200,000 patients in the United States and 3
million globally each year [12]. The primary management strategy is life-sustaining
supportive care and focuses on reducing shunt fraction, increasing oxygen delivery, de-
creasing oxygen consumption, and avoiding further injury. Evidence-based practices
associated with better outcomes for ARDS includes invasive mechanical ventilation
with the use of lower tidal volumes, conservative oxygen therapy, conservative fluid
management, lung protective ventilation, prone positioning, positive end-expiratory
pressure therapy, and usage of neuromuscular blocking agents until evidence of im-
provement is observed [13].
1.2.2 Current Approaches & Challenges for Diagnosis
The Berlin Definition of ARDS [4] requires several criteria to be present for clinical
diagnosis. First, the onset must be acute, defined as worsening respiratory symptoms
occurring within one week of known clinical insult (e.g., sepsis, pneumonia). Bilateral
opacities consistent with pulmonary edema (but not fully explained by pleural effu-
sions, lobar collapse, lung collapse, or pulmonary nodules) are required to be present
on chest imaging. Furthermore, the patient’s respiratory failure must not be fully ex-
plained by cardiac failure or fluid overload. Finally, a moderate to severe impairment
of oxygenation must be present as defined by the patient’s oxygen in arterial blood
(PaO2) to the fraction of the oxygen in the inspired air (FiO2). These patients have
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Table 1.1: The Berlin definition of ARDS.
Timing Within 1 week of a known clinical insult or new or worsening respiratory symptoms.
Chest Imaging Bilateral opacities - not fully explained by effusions, lobar/lung collapse, or nodules.
Origin of Edema Respiratory failure not fully explained by cardiac failure or fluid overload.
Need objective assessmenta to exclude hydrostatic edema if no risk factor present.
Oxygenation
Mild 200 mmHG < PaO2/FiO2 ≤ 300 mmHG with PEEP or CAP ≥ 5 cmH2O
Moderate 100 mmHG < PaO2/FiO2 ≤ 200 mmHG with PEEP ≥ 5 cmH2O
Severe PaO2/FiO2 ≤ 100 mmHG with PEET ≥ 5 cmH2O
CPAP = continuous positive airway pressure, FiO2 = fraction of inspired oxygen, PaO2 = partial
pressure of arterial oxygen, PEEP = positive end-expiratory pressure. ae.g., echocardiography.
a PaO2/FiO2 ratio of less than 300. These criteria are summarized in Table 1.1.
Patients may present with features specific to ARDS in addition to features of the
inciting event. However, the manifestations are so nonspecific that the diagnosis is
often missed until the disease progresses [6]. Current ARDS diagnostic criteria also
require chest x-ray results as an input, since they provide critical information about
whether ARDS is present [4]. However, chest x-rays may not always be available,
particularly at the early stages of care. Furthermore, clinicians may be equivocal or
even disagree about the diagnosis in some patients using chest x-ray [14], which may
result in incorrect labels being provided by an expert.
As ARDS evolves, massive streams of clinical data are collected from their bedside
monitoring devices, and recorded in electronic health records as part of routine care.
These data are asynchronous - with varying temporal frequency (from millisecond to
daily) - and stored in varying formats. Within 24−72 hours after initial presentation
of worsening respiratory symptoms from an inciting event, some patients progress
and develop ARDS. However, clinicians will fail to recognize ARDS if they are un-
able to synthesize the clinical data, obtain chest imaging, and correctly interpret the
findings to make an ARDS diagnosis. The ability of healthcare providers to process
the massive data-streams generated during the care of critically ill patients has been
specifically cited as a potential reason for ARDS miss-diagnosis [15, 11]. Delay in
recognition of this condition, followed by delay in the institution of appropriate treat-
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ment is associated with increased mortality [16]. Yet, only after a healthcare provider
correctly interprets a chest x-ray and synthesize this information with other clinical
data will they correctly diagnosis ARDS.
These challenges clinicians face in diagnosing ARDS is analogous to many other
clinical diagnoses across acute and chronic care settings. The key problem is the syn-
thesis of longitudinal clinical data to recognize a patient’s underlying illness trajectory
and the evolution of disease over time. Only with an appropriate level of suspicion
will a clinician then obtain the right confirmatory diagnostic test and correctly diag-
nose a patient’s condition. By building electronic clinical decision support systems
that models this diagnostic process, the accuracy and reliability of ARDS diagnosis
might be greatly enhanced, thereby ensuring patients receive timely treatments that
improve clinical outcomes.
1.2.3 Data Driven Clinical Decision Support
Although multiple evidence-based management strategies can be provided to pa-
tients with ARDS to improve their outcomes [17], recent evidence suggests that pa-
tients with ARDS are not recognized when they develop this syndrome, and conse-
quently, do not receive the evidence-based therapies proven to reduce mortality [11].
The inability of healthcare providers to process the massive streams of clinical data
generated while caring for these patients has been specifically cited as a potential
reason for poor ARDS recognition [18]. Algorithms that analyze electronic health
record (EHR) data and alert providers when patients develop signs of ARDS have
been proposed as a potential way to improve early ARDS detection [19, 20].
There have been multiple efforts to develop systems that detect ARDS automat-
ically using routinely collected clinical data. At present, simple rule-based electronic
algorithms have been described that analyze EHR data to screen patients for ARDS
[21, 22]. Current systems search the text of radiology reports for language consistent
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with ARDS to identify patients - for example, simple rule-based systems combining
arterial blood gas results with keywords searches of radiology reports. However, for
these systems to be successful, chest imaging must be obtained at the time when
ARDS develops and a radiologist must accurately interpret the radiology image in a
timely manner using language that could be interpreted as consistent with ARDS.
These dependencies are problematic for successful implementation in clinical practice.
Despite these concerns, if a chest x-ray is available, it is informative and should be
integrated into the predictive model’s training process - as such, there is considerable
potential for using data that is unavailable in live clinical environments but available
in training phase. As shown in Figure 1.2, and based on the Berlin Definition, a
chest radiograph is the main confirmatory data necessary for a definitive diagnosis
of ARDS. In addition, patients known to have early evidence of lung injury on chest
x-ray are at high risk for progression to ARDS. However, a chest radiograph may not
always be available in real-time, and even the need to perform a chest radiograph
may not be recognized at early stages. In addition, the frequency at which chest
radiographs are obtained is variable and not amendable to high density collection, in
contrast to physiologic monitoring data.
Figure 1.2: Timeline of ARDS development and clinical data for diagnosis. ECG = elec-
trocardiogram, PPG = photoplethysmography.
Therefore, clinical decision support systems should not rely on chest radiographic
data to determine a patient’s ARDS risk. However, chest radiographs still can provide
critical information about a patient’s current state of illness, and this information
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may be of great value during retrospective training of algorithms that can detect
high risk patients. New learning paradigms, specifically Learning Using Privileged
Information (LUPI), can leverage information only available during model training -
but not required during the testing/deployment phase - to improve the training and
predictive performance of machine learning algorithms.
Furthermore, there may also be many cases, particularly at the early stages of di-
agnosis, where even medical experts may have far less confidence in labeling patients
[8]. Computational models that can account for this uncertainty may be more robust
to the use of noisy or incomplete health data for medical diagnosis. When training
an algorithm to detect ARDS, rather than excluding patients with diagnostic uncer-
tainty, an alternative approach is to use this additional information about diagnostic
certainty during training, which could lead to more efficiently learning and better
generalize to new patient cases.
Learning with uncertainty is a machine learning paradigm that may be well suited
for the task of training an ARDS detection algorithm [23]. The standard machine-
learning classification task is to learn a function f(x) : X → Y , which maps input
training data x ∈ X to class y ∈ Y , where X represents a feature space of each
patient’s covariates and Y is the classification label. The model is trained on well-
defined input data of labeled training examples. However, in certain clinical applica-
tions, there may be uncertainty in the training labels themselves that could adversely
affect model training. In the example of ARDS, there may be challenging cases where
the physician has difficulty determining a patient’s diagnosis due to clinical ambigu-
ity. As a result, this uncertainty and subsequent mislabeling of training data could
adversely affect model training. However, experts may also be able to quantify their
diagnostic uncertainty in these cases. The works later described in this thesis examine
multiple approaches to incorporate a more realistic representation of uncertainty in
real-world applications, avoid discarding uncertain data, and balance the influence of
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such uncertain inputs in the learning algorithm.
Identifying relevant clinical information from massive data streams is a rapidly
advancing field of research in modern medicine. In many healthcare settings, there
is an abundance of rich, continuously measured data collected thorough all stages of
care. However, there is a lack of reliable systems to: 1) extract clinically relevant
features from these data, 2) integrate these features with clinical data to provide
quantitative predictions/recommendations about patient’s health status, thereby as-
sisting clinicians to improve the quality of decision making. Automated systems that
analyze routinely collected data to identify patients with ARDS could improve fidelity
with evidence based practice by alerting physicians when patients are not receiving
standard care [24]. These advances could support precision medicine by improving
rapid yet accurate diagnosis and making just-in-time treatment recommendations
that improve care quality and clinical outcomes.
1.3 Outline of Thesis
In this work, I developed and applied novel computational methodologies to in-
tegrate electronic health data for early detection of disease. This thesis represents
an interdisciplinary research effort encompassing the domains of machine learning,
computer vision, and healthcare.
In Chapter II, I present a practical approach to account for label uncertainty
for detection of ARDS. First, a heuristic approach for clinical experts to quan-
tify their diagnostic uncertainty is described. I then propose an implementation
of instance-weighted support vector machines to incorporate this information during
model training and provide validation/testing results on hold-out dataset from Michi-
gan Medicine. Methods to address using highly correlated longitudinal clinical data
and handle data imbalanced are also examined. Finally, a signal processing method
for quality assessment is presented - this forms the basis of extracting meaningful
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features from physiological waveforms (e.g., photoplethysmogram).
Chapter III focuses on robust and reliable methods for chest x-ray interpretation.
I first discuss the development of an image processing technique for lung segmentation
of complex CXRs from hospitalized patients. A novel feature extraction method is
then proposed for capturing the notion of diffuse alveolar injury as a mathematical
concept. I integrate both of these algorithms and use the extracted features to train
multiple machine learning models to detect ARDS. Performance is evaluated with
cross-validation and testing on a hold-out test set.
Chapter IV introduces the idea of learning using privileged information, a para-
digm that allows for models to use additional data available during training but
may not be accessible during testing (i.e., deployment). Chapter V builds upon this
foundation and extends the existing algorithm’s capabilities to learn from partially
available data. I also integrate the previously developed methods of accounting for
label uncertainty and CXR interpretation into the privileged information paradigm
to train machine learning models for detection of ARDS. The final, comprehensive
model is then validated on EHR, CXR, and waveform data from 500 patients at
Michigan Medicine.
Chapter VI provides a conclusion to the research and work achieved in this the-
sis. A discussion is provided to highlight the importance of highly reliable models to
ensure healthcare providers that the algorithm will consistently perform as expected,
even in the most rigorous tasks. I also address the future direction of between ma-
chine learning and healthcare, with emphasis on advancing the discussion of using
AI in medical settings. Specifically, I provide insight on the U.S. Food and Drug
Administration’s perspective on what it will actually take to get these advancements
into practice to start making an impact towards better patient care.
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CHAPTER II
Accounting for Label Uncertainty
2.1 Introduction
When training a machine learning algorithm for a supervised-learning task in some
clinical applications, uncertainty in the correct labels of some patients may adversely
affect the performance of the algorithm. For example, even clinical experts may
have less confidence when assigning a medical diagnosis to some patients because of
ambiguity in the patient’s case or imperfect reliability of the diagnostic criteria. As a
result, some cases used in algorithm training may be mislabeled, adversely affecting
the algorithm’s performance. However, experts may also be able to quantify their
diagnostic uncertainty in these cases.
The works in this chapter examines a robust method implemented with Support
Vector Machines to account for such clinical diagnostic uncertainty when training an
algorithm to detect patients who develop ARDS. As previously mentioned in §1.2.1,
ARDS is a syndrome of the critically ill that is diagnosed using clinical criteria known
to be imperfect. Uncertainty in the diagnosis of ARDS is represented as a graded
weight of confidence associated with each training label. The work in this chapter also
involves development of a novel time-series sampling method to address the problem
of inter-correlation among the longitudinal clinical data from each patient used in
model training to limit overfitting. Preliminary results show that we can achieve
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meaningful improvement in the performance of algorithm to detect patients with
ARDS on a hold-out sample, when we compare our method that accounts for the
uncertainty of training labels with a conventional SVM algorithm.
Furthermore, this chapter also examines methods for signal quality assessment
used for obtaining features to train the machine learning models. Pulsatile physi-
ological signals are often noninvasive recordings of blood-related physiological mea-
surements used in health monitoring. Although these data can be highly informative,
the quality of these recordings is a major concern in healthcare [25, 26] as many
vital physiological measurements (e.g., respiratory rate, heart rate, and oxygen sat-
uration) are extracted from these signals [27]. The pulsatile nature and similarity
of patterns across these signals makes it possible to develop a general algorithm for
quality assessment.
The work in this chapter examines six propose morphological features that can be
used to determine the quality of the PPG signal and generate a signal quality index.
Unlike many similar studies, this approach uses machine learning and does not require
a separate signal, such as ECG, for reference. The experiments showed that a cost-
sensitive Support Vector Machine (SVM) outperformed other tested methods and
was robust to the unbalanced nature of the data. The covariates used as features are
provided in Appendix A and Table A.1.
2.2 Time Series Analysis of Health Data
The problem of using highly correlated longitudinal clinical data in model train-
ing is often ignored in applications of machine learning in biomedical domains. With
the increased use of electronic health records, clinical data are often available in a
longitudinal format, where specific metrics of health (e.g., vital signs, or laboratory
values) are measured intermittently over time. Analysis of such data requires addi-
tional consideration of the stochastic dependency and time-series nature of these data
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[28], and they should not be considered independent and identically distributed (i.i.d.)
[29], as the data is obviously not. By ignoring the inter-dependency of the time-series
data and the i.i.d assumption, training may result in a biased model that overfits to
the available data and yield unrealistically large values of specificity, sensitivity, and
AUROC [30, 31].
Several techniques, such as dynamic sampling within Markov chain Monte Carlo
methods [32] and Bayesian Changepoint Detection [33], are established for analyzing
the dependency structure of multivariate time series data. Another standard analytic
approach to building prediction models with longitudinal clinical data is using time-
to-event models (i.e. survival models) such as the cox-proportional hazards model
[34, 35]. Such models have been used in clinical research to estimate a patient’s in-
stantaneous hazard of an “absorbing” event such as death based on a patient’s current
clinical features. However, clinical diagnosis may be better suited as a classification
task, where the goal is to determine a patient’s status (e.g., ARDS or non-ARDS)
based on a set clinical features. Classifying patients at time points prior to their
development of a condition, time points after development, and tracking illness re-
covery, are important for informing treatment decisions—tasks less easily addressed
using time-to-event models. In addition, the proportional hazards assumption re-
quired of cox models may be overly constraining, while machine learning classifiers
like the support vector machine may be more robust.
Building on these techniques, similar methods exist to deal with correlated data in
machine learning - such as using a Markov switching process model [36], or partially
linear regression model [37] for longitudinal time-series data analysis or a correlation-
based fast filter method [38] for choosing among highly correlated features in the
model selection process. Beyond the scope of generalized machine learning problems,
additional methods to analyze time series properties exist in many domain-specific
applications, such as stock market prediction with support vector machine and case-
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based reasoning [39], or time-delay neural networks [40] and dynamic time warping
[41] for speech recognition. However, methods addressing stochastic dependency are
largely underdeveloped for applications on longitudinal clinical data.
2.2.1 Stochastic Dependencies in Longitudinal Data
Longitudinal patient data with repeated measurements over time have strong
inter-dependency between each instance for a given patient. Ignoring these depen-
dencies during training may lead to a biased estimator and a flawed learning model.
We address the problem by viewing patients’ time-series data as a mixing process
and consider the data structure as a stationary process with exponentially weakening
dependency, and sample instances in a strategic manner to minimize inter-correlation.
This approach provides a way to measure the decay in correlation [42] among data on
an individual patient over time, and informs a novel sampling strategy to minimize
the correlation among data sampled from the same patient for model training.
Inter-dependency among longitudinal data has been previously conceptualized as
a system under mixing conditions [36]. For a given stochastic process, “mixing”
indicates asymptotically independency – implying that for a stationary process X,
the dependency between X(t1) and X(t2) becomes negligible as |t1 − t2| increases
towards infinity [43]. This mixing structure, while assuming that the dependency
weakens in time, often exponentially, allows local dependency among the data points,
and as such matches the reality of the majority of time-series processed in medicine
as well as many other applications [44].
2.2.2 Thresholded Correlation Decay
In order to address the interdependency of the data, we assumed that each pa-
tient’s time-series data used to develop the ARDS detection algorithm was a mixing
stochastic process and we sampled data according to the quantitative assessment of
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the correlation decay among the data points. This approach limits the degree of
inter-correlation on the data points sampled within the same patient and allows a
more realistic assessment of model accuracy and reliability.
To implement this sampling strategy, we first calculated pairwise correlation dis-
tance matrices to represent dependency over the span of each patient’s time-series
data. Given an m-by-n matrix for each patient’s data, where m is the number of
times the patient was observed, and each observation is treated as 1-by-n row vectors,
the correlation distance between vectors Xa and Xb for a single pair of observations
is defined as:
dab = 1−
(Xa − X̃a)(Xb − X̃b)′√
(Xa − X̃a)(Xa − X̃a)′
√













Using this correlation distance formula, an m-by-m correlation distance matrix
can be derived for all observations on the patient, taken pairwise.
The sampling procedure begins by examining the correlation distances between
Xt and 〈Xt〉 was generated, where Xt corresponds to an instance at the start of a
patient’s time-series data and 〈Xt〉 is the span of all subsequent time-points. Then a
sampling threshold η is set, which represents the point in which the inter-dependency
between data becomes more limited. We chose the threshold value of η to be 1√
2
,
based on literature that suggests values of approximately 1√
2
as an estimate of the
width of a correlation-type function [45]. We also explored other values of η to
understand their effect on the model building process. Figure 2.1 shows the effect
of different sampling thresholds on model performance, including the difference in
model accuracy in the training to testing set and AUROC of the testing set. With
the proposed sampling strategy, SVM performs very well on the training data at any
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threshold. This empirical analysis confirmed that optimal results are achieved when




























































Differences in Accuracy Between Training and Testing Sets
AUROC on Testing Set
Sampling Threshold at 1/sqrt(2)
Figure 2.1: Effects of different sampling thresholds on prediction generalizability. Loss in
training accuracy is determined when predicting on a hold-out test set to assess the effects
of changing the sampling threshold and determining the value for optimal results.
During the data sampling process for each patient, Xt is selected as the start of a
patient’s time-series data. A pairwise correlation distance matrix is then calculated
between Xt and 〈Xt〉, and a data point Xt1 is sampled as the first instance with a
correlation distance of below η from 〈Xt〉. This selected pointXt1 and subsequent time
points beyond Xt1, 〈Xt1〉, are used to re-calculate a new pairwise correlation distance
matrix. A data point Xt2 is then selected in a similar manner as Xt1 from data points
in 〈Xt1〉 with a correlation distance below the threshold of η. The sampling method
is repeated until no further instances of 〈Xtn〉 are below the threshold from Xtn.
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For this specific dataset, we did not utilize the sampling strategy described above
for patient instances with the classification label of ARDS = 1. After inspection of
the data, we observed the correlation decay to behave differently according to the
label, with the data remained highly correlated over time when ARDS = 1 while
correlation decay occurring when ARDS = -1. Therefore, this sampling approach
was only performed on the data when ARDS = -1 while all instances were sampled
when ARDS = 1. This approach effectively samples all positive examples while
undersampling negative examples, which was also necessary given the significant class
imbalance of the two labels [46]. The sampling strategy is shown in pseudocode as
Algorithm 1 and the average decay of correlation from all patients is shown in Figure
2.11 with error bars representing standard error of the mean.
Algorithm 1: Pseudocode for our algorithm to sample time-series data and
reduce inter-dependency.
Input : All available time-series data 〈Xt〉 from each patient.
1 for each patient do
2 partition data into separate bins according to the classification label;
3 if size of either bins is ≤ 4 then
4 sample all available data;
5 else
6 1) select Xt at the start of the time-series data and sample this instance;
7 2) calculate the pairwise correlation distance from Xt to 〈Xt〉;
8 3) sample the first row in 〈Xt〉 with a correlation distance < η and set as the
new Xt;
9 repeat
10 1) set 〈Xt〉 as all points subsequent to Xt;
11 2) calculate the pairwise correlation distance matrix from Xt to 〈Xt〉;
12 3) sample the first row where the correlation distance is < η and set as
the new Xt;
13 until pairwise distance of Xt to 〈Xt〉 > η;
Output: Partial data {Xt, Xt1, Xt2, ..., Xtn} with reduced inter-correlation from
each patient.
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2.3 Signal Quality Assessment
Some of the features in the longitudinal data were obtained from pulse oximetry
- a noninvasive and low-cost physiological monitor that measures blood oxygen lev-
els. While the noninvasive nature of pulse oximetry is advantageous, the estimates
of oxygen saturation generated by these devices are prone to motion artifacts and
ambient noise, reducing the reliability of such estimations. Clinicians combat this
by assessing the quality of oxygen saturation estimation by visual inspection of the
photoplethysmograph (PPG), which represents changes in pulsatile blood volume and
is also generated by the pulse oximeter. The work described in this section investi-
gates methods to use this data by assessing the quality of the waveforms obtained.
Other clinical covariates, in addition to pulse oximetry, used for detection of ARDS
are provided in Appendix A and Table A.1
We propose six morphological features that can be used to determine the quality of
the PPG signal and generate a signal quality index. Unlike many similar studies, this
approach uses machine learning and does not require a separate signal, such as ECG,
for reference. Multiple algorithms were tested against 46 30-min PPG segments of
patients with cardiovascular and respiratory conditions, including atrial fibrillation,
hypoxia, acute heart failure, pneumonia, ARDS, and pulmonary embolism. These
signals were independently annotated for signal quality by two clinicians, with the
union of their annotations used as the ground-truth. Similar to any physiological
signal recorded in a clinical setting, the utilized dataset is also unbalanced in favor of
good quality segments.
We acquired data from bedside telemetry monitors of all patients. The PPG
recording equipment used in this study is Masimo LNCS DCI adult reusable sensor
with GE Medical PDM interface. The sampling frequency of the PPG signals in the
dataset is 60 Hz. For the current pulse oximetry quality study, 46 30-min segments of
PPG signal from different patients with various cardiovascular and res- piratory con-
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Figure 2.2: Segment of PPG signals designated as “bad” quality from clinicians. A signal
segment not annotated as bad quality is assumed to be of good quality.
ditions including atrial fibrillation, hypoxia, acute heart failure, pneumonia, ARDS,
and pulmonary embolism were extracted. 27 (out of 46) of these patients are male, the
average age of the patients is 57 years old, and 37 (out of 46) are Caucasian. Among
these 46 30-min segments, only 12 segments are almost entirely normal, 20 segments
contain long episodes of atrial fibrillation and sinus tachycardia, and the rest contain
sporadic short-term abnormalities (finger tapping, premature atrial contractions and
etc).
Two clinicians independently reviewed PPG signals for uniform, pulsatile changes
in the waveform, based on their experience interpreting such waveforms in clinical set-
tings. Waveforms without a clear pulsatile signal (regardless of arrhythmic episodes,
only based on morphology) that a clinician would not have trusted as accurate in a
clinical setting were annotated as poor quality segments. Certain pulsatile waveforms
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suspicious for artifact, e.g., finger tapping, were also annotated as poor quality. Figure
2.2 depicts a 24-second segment of PPG signal annotated for signal quality by both
clinicians. The union of their labels is used as ground-truth for the algorithm. This
cohort is primarily used for development and validation the proposed algorithms.
2.3.1 Preprocessing and Calibration
In the preprocessing phase, a raw PPG signal is first filtered using a band-pass
Butterworth filter with a 0.5–5 Hz pass band [47]. The next step is peak detection,
wherein potential peaks are only considered if the minimum temporal distance be-
tween two consecutive beats is 70% of the mean PPG beat period. Heart rate is
adaptively extracted from the power spectrum of the most recent 20 s of PPG signal,
as the frequency between 1 Hz and 3 Hz having maximum power spectrum determines
the heart rate.
Unlike many algorithms in the literature that use ECG a reference for beat de-
tection [47], the proposed algorithm is independent of any other signal. Moreover,
positive and negative peaks are detected independently, resulting in two heart rate
signals that should be approximately the same. As described later, the difference
between these two heart rate signals is used as a feature of the algorithm, for any
significant dissimilarity is due to abnormality in beat morphology. Figure 2.3 depicts
examples of raw and filter PPGs with detected positive and negative peaks.
2.3.2 Morphological Features
Six morphological signals/measurements are extracted that are used later to ex-
tract features:
1. Beat waveform with positive peak (the interval between two negative peaks).
2. Beat waveform with negative peak (the interval between two positive peaks).
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Figure 2.3: Preprocessed PPG signals with morphological measurements: (1) beat wave-
form with positive peak, (2) beat waveform with negative peak, (3) negative-to-negative
peak jump, (4) positive-to-positive peak jump, (5) positive and negative pulse duration,
and (6) backward and forward AC components.
3. Change in absolute amplitude between two consecutive negative peaks.
4. Change in absolute amplitude between two consecutive positive peaks.
5. Heart rates extracted from positive peaks and negative peaks (or pulse width).
6. Absolute positive to negative peak amplitude (e.g., the AC component).
These measurements are represented in Figure 2.3. The next step is to use the ex-
tracted signals/measurements to calculate morphological features. All of the proposed
features are based on some distance or dissimilarity from baseline values or templates.
One can think of these templates and baseline values as adaptive averages extracted
from normal beats/signals that have already been seen. For now, assume the algo-
rithm is provided with these adaptive averages and focus on the features; later it is
described how these averages can be calculated.
Let fs be the sampling frequency and suppose T = {tk | k ∈ N, tk = k 1fs
}
is
the set of time samples in the PPG signal. Assume fPPG : T → V is the PPG
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signal amplitude function and U is the bounded set of these amplitude values, i.e.
V = {vk | k ∈ N, tk ∈ T , vk = fPPG (tk) ∈ R} . The features are then extracted as
follows:
2.3.2.1 Normalized pulse duration.


















































∇pi = pi − pi−1 =
 p
+
i − p+i−1 (pi−1, pi) ∈ (P+)
2
p−i − p−i−1 (pi−1, pi) ∈ (P−)
2
and ∇p is the baseline value (as defined in section 2.3.6) of pulse duration. An
example of ∇pi can be seen in Figure 2.3. Given that for every interval between two
consecutive positive (negative) peaks there is a negative (positive) peak, each value
of ∇pi is only associated with the interval between the first positive (negative) peak
to the next negative (positive) peak.
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2.3.2.2 Normalized negative-to-negative peak jump.
Define the set A − = fPPG (P−) =
{





the set of negative peak amplitudes, and let ∇P− be the baseline value for negative-
to-negative peak jump and ∇P be the baseline value for amplitude change from
negative to positive (or positive to negative) peaks, i.e., the baseline value for the
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2.3.2.3 Normalized positive-to-positive peak jump.
Suppose A + = fPPG (P+) =
{





set of positive peak amplitudes and ∇P+ is the baseline value for positive-to-positive
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2.3.2.4 Normalized beat amplitude jump.
Suppose P = P− ∪P+ is the set of positive and negative peak locations and
A = A − ∪A + is the set of peak amplitudes. Then for any consecutive positive and






where ∇Pi = |Pi − Pi−1|.
2.3.2.5 Dissimilarity measure of positive-peaked beats.
Due to nonlinear and non-stationary changes in beat morphology, a nonlinear
time-based stretching or compression of beats is necessary to perform effective tem-
plate matching [48]. As mentioned earlier in this section, beat waveforms with positive
peak (interval between two negative peaks, see Figure 2.3) are extracted and normal-
ized into the range [0,1]. Then, dynamic time warping (DTW) [48] is used to align
the PPG with a template as constructed in §2.3.6. Finally, KL divergence [49] is used


















t+k | 1 ≤ k ≤ m
}
are two aligned time









i = 1. In the proposed algorithm, D (T
+‖B+)
is used as the dissimilarity measure of positive-peaked beats feature.
2.3.2.6 Dissimilarity measure of negative-peaked beats.
Applying the same procedure as described above, a dissimilarity measure of neg-
ative peaked beats, i.e. D (T−‖B−) , is calculated in which B− =
{




t−k | 1 ≤ k ≤ m
}
are two time series of beat and template with negative










2.3.3 Templates and Baseline Values
As described in §2.3.2, the proposed features D (T−‖B−) and D (T−‖B−) require
templates, while the features ∇pi,∇P−i ,∇P+i , and ∇Pi need baseline values. A dis-
tinct component of the proposed algorithm is the individually generated template and
value for each waveform. This section describes how to generate these templates.
2.3.3.1 Initial template and baseline value generation.
The proposed algorithm uses the first T seconds of each waveform in the calibra-
tion phase, during which preprocessing and then peak detection is performed on the
segment. Based on this segment and the peak locations, the baseline value ∇p is the
averaged pulse duration, ∇P− the average negative-to-negative peak jumps, ∇P+ the
average positive-to-positive peak jumps, and ∇P the average amplitude change from
negative to positive peaks. In the results presented in this paper, T = 20 seconds is
chosen.
Formally, suppose P+0−20 =
{
p+i | i ∈ N, p+i ∈ T , 0 < p+i < 20
}
and P−0−20 ={
p−i | i ∈ N, p−i ∈ T , 0 < p−i < 20
}
are the sets of positive and negative peak locations
in the [0-20] time interval, and assume there are m positive and m negative peaks in
the 20 s segment, i.e.,
∣∣P+0−20∣∣ = ∣∣P−0−20∣∣ = m (the procedure is the same if the num-








. Also P0−20 = P
−
0−20∪P+0−20 and A0−20 = A −0−20∪A +0−20

















| fPPG (pi)− fPPG (pi−1)
are the initial baseline values that will be used in the proposed algorithm. The
value of ∇p is calculated based on the power spectrum of the 20 s segment, as the
frequency between 1 and 3 Hz that has the highest power is the inverse of the heart
rate frequency [27], i.e., 1∇p
In order to extract an initial template with positive peak T+, first the m − 1
positive-peaked pulses are sorted with respect to their pulse width. If the template
pulse duration is chosen to be the mode of pulse duration (the most frequent pulse
duration) in the 20-second segment, then the template T+ can be calculated as the
average of beats that have the same temporal duration as the mode of pulse duration.
If the mode of pulse duration is not unique, the median of pulse duration (the middle
value for pulse duration) in the 20 -second segment is chosen, and then the beats
that have the width closest to the median of pulse duration will be aligned (e.g., by
using DTW) or interpolated and then averaged to achieve the template T 4. The same
procedure is applied to negativepeaked beats in order to extract the template with
negative peak T−.
2.3.3.2 Updating template and baseline values.
As mentioned above, the first T seconds of each waveform is used as the calibration
phase to extract initial individual-specific templates and baseline values, with T = 20
seconds chosen for this paper. Since it’s possible that the first segment is noisy, the
initial baseline values and templates may be invalid. Thus, two criteria for accepting
a segment as valid are imposed:
1. The number of positive or negative peaks should be more than 0.95 × T ; i.e.,
on average a heartbeat should occur at least every 0.95 s.
2. At least one third of pulse widths (pulse durations) are within 5% of pulse
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duration mode/median (as mentioned in the previous section, if the mode of
pulse duration is not unique, the median of pulse duration is chosen for template
width).
If both of these conditions are satisfied, the first T seconds are accepted for initial
baseline values extraction, otherwise the T -second window is iteratively slid for 1 s
until both conditions are satisfied (e.g., intervals of [0,20] [1,21], etc.).
Due to the non-stationary nature of the source, after the initial calculation of
the baseline values and templates, an adaptive algorithm for updating these baseline
values and templates is necessary, particularly if the PPG signal has long duration.
As such, after calculating the features of each segment using the baseline values
and templates of the previous segment, these baseline values and templates are then
updated to be used in the subsequent segment. Similarly, an interval is accepted for
updating the baseline values and templates if it also satisfies the two aforementioned
criteria.
2.3.4 A Standard Algorithm










where ∇p,∇p−,∇p+,∇P ,D (T+‖B+) and D (T−‖B−) are the features described in
§2.3.1. Using a standard algorithm based on decision rules, these values can be com-
pared with thresholds for classification purposes. The hypothetical thresholds for a
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simplistic algorithm can be achieved experimentally using training data. After choos-
ing the thresholds, the six features can be used to classify each beat, more specifically
each interval between any two peaks (positive to negative peaks or negative to posi-
tive peaks), into a good or poor quality interval.
In this case, a standard algorithm assigns the “poor quality” label to each interval
between two consecutive peaks if any of the six features are greater than the threshold.
Formally speaking, for an interval set Ppipi−1 = [pi−1, pi] between any two consecutive
peaks (note that I pipi−1 ⊆ T
)
define the feature function ffeature : T ×U → R6 as a
function from the set of time samples and bounded set of PPG values to the feature
space. The set of poor quality intervals is then:
T Poor =
{













where τ = [τ1, . . . , τ6] ∈ R6 is a vector of thresholds on the six features, and the
inequality is performed component-wise. Obviously the set of good quality signal is




= T −T Poor . This algorithm is
used later for threshold optimization.
2.3.5 Interval Classification and Signal Quality Index
One of the primary reasons for measuring PPG quality and reliability is that
other important signals such as oxygen saturation utilize PPG in their formation.
In general, oxygen saturation values are averaged over a moving window of PPG
signal. In the ARDS dataset, the pulse oximetry hardware (PPG recording device)
calculates every value of oxygen saturation based on the last 8 s of PPG signal.
Consequently, having isolated poor quality beats/intervals is insufficient to label a
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PPG segment as “poor quality.” Thus, for an interval Ttk of length 8 s such that
Ttk = {ti | ti ∈ T , tk − 8 < ti ≤ tk}, the signal quality index (SQI) for that window
is defined as:
SQI (Ttk) = 1−






which is always a number between zero and one. As discussed in section 3.4, the
SQI for any given interval will be compared with a pre-determined rate (threshold)
for classification.
2.3.6 Learning Models and Decision Rules
In this paper, two different training/testing frameworks are considered:
1. A standard learning method in which a single model is trained on 6-dimensional
samples (Figure 2.4a).
2. Six similar models that are trained on each sample feature separately, followed
by a decision rule (Figure 2.4b).
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Figure 2.4: Training/testing frameworks used for the initial study: (a) a framework for
training/testing model on 6-dimensional samples (b) a framework for training/ testing
six similar models on each 1-dimensional sample feature followed by decision rule, which
basically is a logical “or” operation on the six outcomes.
The principle reason for considering the second model is the nature of the proposed
normalized features. For a normal PPG beat all the features are expected to be close
to zero; while for a poor quality interval, the absolute value of at least one of these
features is expected to be greater than a threshold.
To support this argument, Figure 2.5 represents the cumulative distribution func-
tion (CDF) of the absolute value of the normalized negative-to-negative peak jump
feature
∣∣∣∇P−i ∣∣∣ for both classes. This figure shows that the larger the value of ∣∣∣∇P−i ∣∣∣,
the worse the quality, and this is valid for all the features. Thus, in the second frame-
work, the decision rule is simply a logical “or” operation on the outcomes of each
trained model on individual features.
31
Figure 2.5: Cumulative distribution function of ∇P−i , the normalized negative-to-negative
peak jump.
2.4 Accounting for Label Uncertainty
After developing methods to process the time-series data and performing signal
quality assessment, the next step in developing the proposed machine learning model
is to account for uncertainty of the classification labels. Data in numerous applications
of machine learning may have uncertainty in their training labels or the input data
(i.e., features) might be corrupted by uniform/non-uniform noise distribution [50].
For example, in medical applications, precisely determining a prognosis might be
difficult due to erroneous lab results or a shirt in baseline perspective as patients may
vary in describing their symptoms. As a result, some cases used in algorithm training
may be mislabeled, adversely affecting the algorithm’s performance.
The diagnosis of ARDS is made based on clinical criteria, but even clinical experts
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may disagree or have uncertainty about the diagnosis in some patients. However,
experts may also be able to quantify their diagnostic uncertainty in these cases. As
previously mentioned, label uncertainty can be incorporated as weights within a SVM
model. These weights determine the relative penalty of misclassification of training
set points. Information about the uncertainty level of an ARDS diagnostic label
provided by clinical experts can also prove useful when training a system for ARDS
detection. We present a robust method implemented with support vector machines
(SVM) to account for such clinical diagnostic uncertainty when training an algorithm
to detect patients who develop ARDS.
A group of expert clinicians reviewed all patients for the development of ARDS
based on the Berlin definition [4]. As ARDS is a clinical diagnosis without a gold
standard, we were unable to “benchmark” expert performance. However, because
the inter-rater reliability of ARDS diagnosis is known to be poor in patients with
acute hypoxic respiratory failure [51], these patients were reviewed independently by
3 experts, and their ratings were averaged. In addition to determining whether the
diagnosis was present (yes or no) and record the time of ARDS onset among positive
cases, the experts were also asked to provide their confidence level in the diagnosis
label (high, moderate, low, equivocal). This 4-point confidence scale was carefully
tested on the experts prior to use in this study, and felt to reasonably capture the range
of uncertain that they might have when reviewing patient cases. Their diagnosis label
and confidence level could then be converted to a 1 − 8 scale, as depicted in Figure




Figure 2.6: Accounting for label uncertainty and label generation. (a) Multiple expert
clinicians were asked to independently review patients’ data and determine if any individuals
had ARDS. Clinicians were also rated their confidence of the diagnosis as equivocal, slightly
confident, moderately confident, or highly confident. (b) The diagnosis and confidence were
converted to a scale between 1-8. The final label was generated from aggregating these
reviews to ensure correctness and consistency of the diagnosis. A label of -1 (non-ARDS)
was assigned if the averaged review was below or equal to 4.5, and a label of 1 (ARDS) was
assigned if the averaged review was above 4.5
2.4.1 Support Vector Machines
A support vector machine (SVM) is a supervised machine learning algorithm based
on the idea of finding a hyperplane that best divides a dataset into two classes [52].
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For a binary classification task, the hyperplane can be represented as a line that
linearly separates the two classes in a set of data. The SVM uses a subset of the
training data as support vectors to determine the optimal decision boundary, which
can be further adjusted to control the acceptable rate of miss-classification. SVMs
generally tend to work well on smaller datasets due to efficient usage of a subset of
training data as support vectors - reducing the tendency of larger machine learning
models to overfit. Furthermore, kernel functions can be used to transform the data
input into higher dimensional planes for better separability.
For this study, we train a linear SVM model to discriminate between an ARDS
and non-ARDS diagnosis. Given a set of training data:
(x1, y1) , . . . , (xn, yn) xi ∈ X, yi ∈ {−1, 1}
SVM first maps the training sample vector x ∈ X into a vector (space) z ∈ Z.
It then constructs the optimal separating hyperplane by learning the decision rule







s.t. ∀1 ≤ i ≤ n, yi (w · zi + b) ≥ 1− ξi
∀1 ≤ i ≤ n, ξi ≥ 0
(2.1)
where C > 0 is a hyperparameter and ξi is the slack variable. C is a regularization
parameter to influence the slack variable, which allow certain constraints to be vio-
lated (i.e., perfect linear separability). C essentially controls the level of acceptability
for misclassifying each training example. For large values of C, the optimization will
choose a smaller-margin hyperplane if that hyperplane does a better job of getting all
the training points classified correctly. Conversely, a very small value of C will cause
the optimizer to look for a larger-margin separating hyperplane, even if that hyper-
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plane misclassifies more points. Grid search [53] was used to determine the optimal
value of C over ∈ {0.001, 0.01, 0.1, 1, 10, 100, 1000}.
















∀1 ≤ i ≤ n, 0 ≤ αi ≤ C
whereKi,j , K (zi, zj) is the kernel in the decision space with the decision function
f(z) = w · z + b =
n∑
i=1
yiαiK (zi, z) + b (2.2)
2.4.2 Incorporating Label Uncertainty
To investigate learning with uncertain data, we briefly explore the changes in the
learning formulation when moving from the standard machine learning to learning
with uncertainty. Almost all existing machine learning paradigms use the following
learning scheme: given a set of training examples (xi, yi) , i = 1, . . . , N, ) in which
xi ∈ X form the input attributes/features and yi ∈ {−1, 1} is the output class, find a
function fγ(x) : X → {−1, 1} (where γ ∈ Λ represents the set of parameters used in
the function) to learn / generalize a mapping between the input and the output. In
the training phase, the parameters γ that minimizes a cost function, defined over the
training examples, identifies the solution fγ(x). Such a cost function often considers
both the magnitude of the estimation error on the training data and the complexity
of the model (to avoid overfitting).
In learning with uncertainty, the training examples while some examples have
certain labels, i.e. (xi, yi) , i = 1, . . . , N1, the rest have some level of uncertainty on
their labels, i.e. (xi, yi, li) , i = N1, . . . N, where 0 < li ≤ 1 is the level of confidenc
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(i.e., lack of uncertainty) over sample i. While the exact formulation of learning with
uncertainty might vary, the SVM-based formulation might be the most insightful
approach. Intuitively speaking, note that in the standa SVM the main objective is to
find parameters w and b in a hyperplane wTx+ b that separates positive and negative
examples while keeping the value of w small (controlling the complexity of model).
In the formulation of SVM with uncertainty, as described in [35], the following
optimization problem is solved:
We implement the following formulation of SVM to account for label uncertainty
















zi = (|li − α| − β) ∗ γ + δ
This formulation incorporates the slack variable ξi to permit some misclassifi-
cation and also includes the penalty parameter C to establish soft-margin decision
boundaries because ARDS and non-ARDS examples are not linearly separable. In
this implementation, support vectors that are based on patients’ data with high la-
bel confidence are given more weight and influence in the SVM decision boundary.
Uncertainty in the label (li), as shown in Figure 2.6, is incorporated within (zi) to
directly influence C. The formula for zi combines two linear transformations for un-
certainty in the label annotation (li) and generate a scalable weight to that specific
observation.
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In this application, we set α = 4.5, β = 3.0, γ = 20, and δ = 90, which scales li,
with a range of 1-8, into the weighting zi, with a range between 40-100 in increments
of 20. As a result, labels with high confidence (eg. li = 1 or 8) receive the weight
zi = 100, while equivocal labels (eg. li = 4 or 5) receive the weight zi = 40. zi is
then normalized to 1. This formula for zi adjusts sample weighting based on li and
rescales the C parameter as Ci for each observation in a patient’s data structure so
that the classifier puts more emphasis on points with high confidence.
2.5 Application
In this study, the primary learning algorithms we compare are linear SVM with
and without label uncertainty. 5-fold cross validation was performed on the training
data to find the optimal value of the hyper-parameter C using grid search [53] over
C ∈ {0.001, 0.01, 0.1, 1, 10, 100, 1000}. We then re-trained the model on the entire
training set using this optimal C parameter. This updated model was then used
to classify patients in the hold-out dataset using all their data (e.g., no sampling
was performed on the holdout data). The model predictions for each patient in the
holdout sample (e.g., ARDS = 1 or -1) are then compared against the label assigned
by the majority of experts reviewing the patient. We also compare the performance
of our proposed SVM method with Logistic Regression and Random Forest (using
the same subsampled training/testing bins and 5-fold cross validation partitions) to
determine if the achieved results are equivalent or superior to other state-of-the-art
methods.
A simplified protocol of this analysis, including data pre-processing, sampling from
the training data to limit inter-correlation, hyper-parameter optimization with 5-fold
cross-validation, and hold-out testing is shown in the flowchart of Figure 2.7.
To ensure that our proposed sampling strategy and threshold still maintains for
SVM with label uncertainty, we repeat the previous analysis to show the effect of
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Figure 2.7: Flowchart of the study’s experiment design, with 5-fold cross-validation and
hyper-parameter optimization using grid search. All samples from the same patient are
kept exclusively in either the training or testing set. Hyper-parameter optimization was
implemented for separately each model (with and without label uncertainty weight) to give
an accurate assessment of performance.
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different sampling thresholds on prediction generalizability. Figure 2.8 confirms that
optimal results are achieved when the sampling threshold is approximately 0.7, which
supports the previous analysis and the literature suggested value of 1√
2
.
























































Differences in Accuracy Between Training and Testing Sets
AUROC on Testing Set
Sampling Threshold at 1/sqrt(2)
Figure 2.8: Effects of different sampling thresholds on prediction generalizability. We con-
firm that the sampling strategy and threshold effects observed in Figure 2 is maintained
when the SVM model is formulated to account for label uncertainty.
2.5.1 Data
The patient cohort included consecutive adult patients hospitalized in January
of 2016 with moderate hypoxia, defined as requiring more than 3 L of supplemental
oxygen by nasal cannula for at least 2 hours. The cohort was enriched with additional
patients who developed acute hypoxic respiratory failure (PaO2/FiO2 ratio of < 300
mm Hg while receiving invasive mechanical ventilation) in February and March of
2016 who are higher risk for developing ARDS.
A total of 401 patient cases were available from the study cohort. Within this
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dataset, 48 were positive for ARDS and the remaining 353 were negative. Two-thirds
of the patients were used in the model training process while the remaining one-third
were kept as a hold-out set for testing. All samples from the same patients are kept
exclusively in either the training or testing set (not both) to avoid bias in the data.
In patients who developed ARDS, data collected before the time of onset were
labeled as “no ARDS,” while data collected after the time of onset were labeled as
“ARDS.” In total, 48 of the patients in the cohort were diagnosed with ARDS with
a confidence of 5 or higher after expert review.
Data was first normalized to prevent features with large dynamic ranges from
dominating the separating hyperplane. Then the training data was sampled using
the proposed sampling method described previously to minimize correlation between
data points on the same patient. Prior to sampling, the training set contained 13,722
total instances, 736 of which were positive. After sampling, there were 1,893 total
instances, 736 of which were positive.
Time-stamped vital signs and laboratory values were extracted from each patient’s
electronic health record (EHR) from the first six days of hospitalization and included
as clinical features (covariates) to train the ARDS algorithm. Only routinely acquired
vital signs and laboratory values with potential for association with ARDS were
included, based on guidance from clinical experts. The covariates used as features
are provided in Appendix A and Table A.1. This approach minimized the total
number of features in the model to 24 variables commonly used in clinical practice
and statistical feature selection techniques were not utilized prior to model training.
Patients were observed every 2 hours with previous data carried forward until a new
value was recorded. If clinical data was missing on a patient because the vital sign
or laboratory tests was not performed, it was imputed as a normal value. This is
standard approach when developing clinical predictions models and assumes data
is not collected because the treating clinician had a low suspicion that it would be
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abnormal [54, 55].
EHR data also include records such as chief complaint, medications, comorbidi-
ties, age, gender, injury scores, and laboratory results. Most of these attributes are
measured at relatively fixed time intervals that are much less frequent than the rate
at which other physiological signals are recorded. In the database we will use for this
project, almost all these records are available for all patients.
2.5.2 Results
Signal quality assessment for beat-scale and fixed interval-scale analysis are pre-
sented in Table 2.1, Table 2.2, and Figure 2.9. The decision tree model and threshold
optimization both used the second framework in their learning process, while the en-
semble of decision trees and SVM used the first framework. The ensemble of decision
trees and threshold optimization are the two algorithms that used under-sampling.
Both of these methods were also significantly faster to train than those which used
the first framework. In comparing model performance on the training and testing
datasets, the tree based algorithms overfitted the training data, while SVM and the
threshold optimization algorithm have almost the same performance on both datasets.
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Table 2.1: Performance comparison of decision tree, the ensemble of decision trees, SVM,
and threshold optimization in beat-scale analysis.
DT EDT SVM TO
Undersampling No Yes No Yes
Framework Two One One Two
Running time (sec) 5 450 375 20
Train
Accuracy 96.92 100 85.37 80.02
Sensitivity 99.92 100 86.05 82.82
Specificity 96.70 100 85.31 80.67
Test
Accuracy 75.02 88.85 83.02 80.66
Sensitivity 73.01 70.03 85.45 82.38
Specificity 75.14 90.04 82.82 80.50
DT = decision trees, EDT = ensemble of decision trees, SVM = support vector machines,
TO = threshold optimization. The running time is the average time needed to train the algo-
rithms on 31 30-min PPG signals and test on 15 30-min PPG signals.
Table 2.2: Comparison of decision tree, the ensemble of decision trees, SVM, and threshold
optimization in interval-scale analysis.
DT EDT SVM TO
Sensitivity 88.96 91.56 93.25 90.05
Specificity 86.30 91.97 91.90 89.45
Corresponding Rate 0.45 0.40 0.70 0.65
DT = decision trees, EDT = ensemble of decision trees, SVM = support vector machines,
TO = threshold optimization. Please note that the rate in the table corresponds to the best
performance.
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Figure 2.9: ROC curves of the methods used for signal quality assessment.
The best results achieved with SVM yielded a sensitivity of 93.25% and specificity
of 91.90% for a rate of 0.7. Figure 2.10 depicts a visual example of the SVM model
used for classifying PPG signal quality on the three intervals. In comparison, the
best performance of the decision tree model for fixed interval-scale analysis yields a
sensitivity of 88.96 and specificity of 86.30 for a rate of 0.45. The best result achieved
with an ensemble of decision trees is sensitivity of 91.56 and specificity of 91.97 with
rate of 0.40.
In the first interval (0–8 s) both the algorithm and annotation have poor quality
segments in beat-scale, which is less than 5.6 (8 × 0.7) seconds; thus, this interval is
not considered poor quality by both the algorithm and the annotation. The second
interval (8–16 s) had more than 5.6 s of poor quality beat-scale segments using the
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algorithm, but slightly less than 5.6 s of poor quality beat-scale segments using the
annotation, therefore this interval is labeled as poor quality using the algorithm, but
not using the annotation. The last interval (16–24 s) has more than 5.6 s poor quality
beat-scale segments in both algorithm and annotation.
Figure 2.10: Signal quality assessment on fixed interval-scale segments. This example uses
an SVM model with rate (threshold on interval SQI) 0.7.
In addition to Table 2.1, the effect of uniform and non-uniform undersampling has
been tested on SVM and decision tree: non-uniform undersampling used in threshold
optimization reduces the performance of both algorithms, while uniform undersam-
pling has no significant effect on SVM (in its cost-sensitive SVM formulation) and
a negative effect on decision tree performance. Based on Figure 2.9 and Table 2.2,
SVM and the ensembles of decision trees outperform the other two methods in the
fixed interval-scale analysis. Overall, the cost-sensitive SVM with Gaussian kernel
outperform the rest, while the proposed threshold optimization is significantly faster.
The proposed thresholded correlation decay method (§2.2.2) is applied to the
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dataset used for model training. The average correlation decay for each patient’s
data is shown in Figure 2.11. On average, the correlation between Xt and 〈Xt〉 drops
below η at a distance in time of around 22 hours. Figure 2.12 shows the decay of
correlation to be different when the data was analyzed separately according to the
classification label: decay of correlation is observed when ARDS = -1 but not observed
when ARDS = 1.



















Average from All Patients
Sampling Threshold at 1/sqrt(2)
Figure 2.11: Average decay of correlation from all patients. Error bars represent standard
error of the mean and each point represents correlation in relation to time (hours) from the
initial observation sampled on each patient.
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Average from All Patients
Sampling Threshold at 1/sqrt(2)
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Average from All Patients
Sampling Threshold at 1/sqrt(2)
Figure 2.12: Decay of correlation from all patients stratified by classification label. (A)
depicts the average correlation decay during negative diagnosis of ARDS and (B) corre-
sponds to the positive diagnosis of ARDS. Error bars represent standard error of the mean
and each point represents correlation in relation to time (hours) from the initial observation
sampled on each patient.
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Therefore, the sampling under η approach was performed on the data when ARDS
= -1, which reduce the number of negative examples for model training. Due to the
lower number examples, and lack of correlation decay when ARDS = 1, sampling was
not performed as it would have further exacerbated the class imbalance.
We benchmarked our proposed SVM method utilizing uncertainty in the label to
SVM with a misclassification cost function proportional to the weight of imbalance
in the datasets and other standard classification models, such as Random Forest and
Logistic Regression, in Table 2.3. We also compared our sampling strategy to an
alternative method that utilizes random sampling on negative examples to yield a
2:1 negative to positive ratio from each patient to provide a more balanced dataset -
the results for this approach is provided in Table 2.3. In addition, we also examined
performance without sampling (using all available data).
Table 2.3: Performance of logistic regression, random forrest, SVM, SVM with a class-
weighted cost function, and SVM with label uncertainty.
Sampling Based on the
Proposed Correlation Decay Method
Random Sampling for







Accuracy AUROC Accuracy AUROC
Logistic Regression 72.63 72.65 30.07 42.67 69.82 69.79 66.21 64.54
Random Forrest 74.34 74.88 33.92 47.51 71.11 72.54 68.73 69.03
Support Vector Machines 74.92 75.42 37.97 51.14 72.53 73.61 69.20 71.52
SVM w/ Class Weight 78.04 81.13 45.71 59.18 74.78 77.03 70.94 71.22
SVM w/ Label Uncertainty 81.57 85.48 52.85 64.50 76.98 79.89 71.88 74.31
When the SVM was trained to account for uncertainty in the label, we observed
over 10% improvement of AUROC (0.8548 versus 0.7542) compared to the conven-
tional SVM learning algorithm (Figure 2.13) when judged in the holdout sample.
When the algorithms were benchmarked at a sensitivity of 95% and 90% (to ensure
few ARDS cases are missed), the SVM model that accounted for label uncertainty
also had improved specificity and outperforms the standard model. These sensitivity
levels were set to high levels because it is important clinically for a model to have a
high sensitivity and not miss cases of ARDS.
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SVM w/ Uncertain Labels
Random Guess
Figure 2.13: ROC curves comparing SVM with and without label uncertainty. Performance
metrics are reported in Table 2.3.
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2.6 Discussion
We present a robust machine learning algorithm to detect Acute Respiratory Dis-
tress Syndrome among hospitalized patients using routinely collected electronic health
record data. We report an increase of approximately 10% in AUROC in a hold-out
data set when label uncertainty is incorporated in the learning process as a weight
on classification penalty, when compared to a conventional SVM learning model.
Our proposed SVM model was trained by incorporating a clinical expert’s uncer-
tainty in each patient’s classification label as a constraining weight of confidence on
the SVM’s box constraint. Rather than treating label uncertainty as stochastic noise,
this approach leverages information about the degree of uncertainty of each label, as
provided by clinical experts, to improve the efficiency of model training. Our im-
plementation of label weighting (zi) directly influences the C parameter and rescales
the cost of misclassification according to uncertainty associated with each label (li).
Support vectors that are based on the data from patients with high label confidence
are given more influence in the SVM decision boundary while instances with more
uncertainty are assigned less weight when determining the SVM hyperplane. In future
works, alternative mappings between the label uncertainty (li) provided by clinical
experts and label weighting (zi) used to find the SVM decision boundary should also
be explored.
In addition, we performed a novel time-series sampling method, guided by the
theory of mixing in stochastic processes, to limit the amount of correlation among
data points on the same patient over time. Due to the time-series structure of a
patient’s longitudinal health data, each instance is not independent from another.
We explored whether the data could be represented under mixing conditions and
implemented a novel sampling strategy for minimizing inter-correlation among data
points in the training data. For the data to be represented under mixing conditions,
the correlation between data on the same patient should decay over time such that
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CF,G(n) → 0 as n → ∞. A plot of the correlation function of the data in Figure 6
supported this assumption overall, but not for the data with a classification label of
ARDS = 1.
It may not be appropriate to assume all data types can be represented under
mixing conditions, therefore, plotting the correlation function of the data is essential
prior to utilizing the sampling algorithm. When patients were diagnosed with ARDS,
we found their data to have very high inter-correlation with little observable decay
– indicating a strong mixing process. Therefore, the proposed sampling method
would have been unsuccessful in reducing inter-correlation and would yield very little
data instances available for training. This finding made sense when interpreted from
a clinical point of view. When a patient is admitted to the emergency room for
pulmonary injury (eg. sepsis) and has not yet reached the critical stage of ARDS,
their condition rapidly changes as a result of clinical intervention or decline of health,
resulting in less stability and inter-correlation in the recorded data. If the patient
develops ARDS, less rapid change in the data would be observed since ARDS is
recognized as the “final pathway” of pulmonary damage [56].
Since there were significantly more negative than positive examples, we decided
against using the sampling strategy when ARDS = 1, which ensured a more balanced
number of positive and negative examples in the training data. As minimal correla-
tion decay was observed among the data when ARDS = 1, implementing the sampling
strategy for those data instances would have led to further imbalance among posi-
tive and negative examples, and limited the model’s ability to learn a good decision
boundary. Our sampling approach utilized a pairwise correlation distance matrix to
quantify dependency within the data structure. There are many ways to quantify the
measurement of dependency between Xt to 〈Xt〉. Bradley et al provides a comprehen-
sive list of mathematical definitions for dependency coefficients to define these mixing
conditions [57] and measure decay of correlations [42]. In the future work, we will
51
perform a more comprehensive examination of the data structure using formalized
definitions of mixing, such as quantifying dependency with the α-mixing coefficient.
Our sampling method outperforms using all available data (no sampling) from the
EHR by producing a much balanced dataset for training and minimizing dependencies
in each patient’s time series data, making it closer to the state of being i.i.d. We
also compared our sampling algorithm to randomly sampling on negative examples
to yield a 2:1 negative to positive ratio from each patient. This random sampling
method also provides a balanced dataset for training, and as a result, we observed
an increase in accuracy and AUROC from all algorithms when compared to training
without sampling. However, compared to our proposed sampling strategy, random
sampling does not achieve as high performance metrics because it does not account for
correlation and may be sampling repeated measurements with strong dependencies,
and therefore is not as robust as our method.
This study used a linear SVM for the ARDS model. In preliminary work not
shown, we found that an SVM with a non-linear kernel (RBF) had less consistent
results. Although the SVM with RBF kernel generally outperformed linear SVM on
training dataset, it had inferior performance (accuracy and AUROC) on the hold-out
set. Even with 5-fold cross-validation and grid-search hyper-parameter optimization
(of C and gamma), we found the performance of the SVM with RBF kernel to be lower
on the test set, and standard deviation of the results (after multiple random train-
test splits) to be 2-3 fold larger than the linear SVM. We speculate that overfitting
possibly occurred because of lower sample size and the number of variables used as
features for machine learning. Because linear SVM was more robust, we chose to
focus on using label uncertainty in the modeling process using only linear SVM.
With more clinical data, it would be worthwhile to investigate whether incorpo-
rating both label uncertainty and a non-linear SVM model would lead to improved
model performance. The electronic health record may contain additional data that
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could be added to our model. Evaluating the performance of the training approach
that considers label uncertainty in a higher dimensional space would be of value;
however, to limit the possibility of overfitting with our current small dataset size, we
have focused on using features that are routinely used for clinical evaluation of ARDS
in the current study.
We believe this project makes a significant contribution towards solving tradi-
tional classification problems in the context of biomedical and clinical applications.
In medicine, there is almost always a degree of uncertainty when assigning a patient
to a medical diagnosis. Yet, that diagnosis label may then be used as the classification
label or predictive outcome during a machine learning task. Typically, the diagnostic
uncertainty associated with the label is not considered during model building. We
show how an expert clinicians’ confidence in a diagnosis label can be used as vital in-
formation in the model training process. Exploiting the known diagnostic uncertainty
within a medical domain is a generalizable approach that could be used in many med-
ical applications. For example, sepsis is a clinical condition where early recognition
is import for optimal patient care. However, diagnostic uncertainty is common [58],
limiting ability to develop robust algorithms for sepsis detection. Incorporating label
uncertainty when training an algorithm for sepsis detection may improve algorithm
performance in a manner similar to ARDS.
It would also likely be of value to further develop approaches to incorporate label
uncertainty into other machine learning frameworks besides SVM, such as random for-
est and neural networks. Since uncertainty in medical diagnosis occurs so commonly
in clinical practice, accounting for label uncertainty with these learning algorithms
may be highly applicable in other healthcare applications.
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CHAPTER III
Robust Yet Reliable Methods for Analysis of
Complex CXRs
3.1 Introduction
Imaging is integral to the care of ARDS patients that are critically ill. As previ-
ously mentioned in §1.2.1, CXR features of ARDS usually develop 12-24 hours after
initial lung insult. Although appearances in manifestation can vary depending upon
the stage of the disease, CXRs of patients typically exhibit characteristics of diffuse
bilateral opacities with dense consolidation. Because of this, CXRs are a critical re-
source that can support an early diagnosis and provide evidence-based management
strategies to patients with ARDS to improve their outcomes [56]. Identification of
pulmonary opacification is a requirement for diagnosis of ARDS; however, radiolog-
ical features by themselves are nonspecific and may not be correlated with clinical
findings [4, 59]. As a result, inconsistencies in interpretability of chest imaging and
poor inter-rater reliability suggest that patients with ARDS are not recognized when
they develop this illness. Consequently, they do not receive the therapies proven to
reduce mortality [60, 51].
At the time that a CXR is made available, radiology interpretation plays the
major role in diagnosis of ARDS. However, due to the noisy nature of these images,
54
the expertise of the interpreter, and other factors, the reliability of chest radiograph
interpretation for ARDS is low among clinicians. There is a clear need for image
processing algorithms to quantitatively express and extract the changes in the CXR
(compared to normal cases) and evaluate the presence and severity of ARDS.
In this chapter, I present the development of an image processing technique for
lung segmentation of complex CXRs from hospitalized patients. A novel feature
extraction method is then proposed for capturing the notion of diffuse alveolar injury
as a mathematical concept. Finally, I integrate both of these algorithms and use the
extracted features to train multiple machine learning models to detect ARDS.
3.2 Challenges
Although many methods for lung segmentation exist in the literature [61, 62, 63,
64, 65, 66, 67], they are primarily designed and evaluated on high quality, standardized
chest radiographs from controlled studies or outpatient settings that may not be
representative of more complex CXRs from hospitalized patients. This is problematic
for many patient populations, especially the critically ill, whose CXRs tend to have
characteristics of varying image quality (e.g., dynamic range, sharpness), presence
of introduced medical devices [68], diverse body habitus [69], and manifestation of
disease [70]. As a result, these methods may not generalize and perform as well on
CXRs obtained from other clinical settings.
To address this challenge, we collected data for algorithm development in a “strat-
ified by severity” approach represent greater variety in patient population and hetero-
geneity of disease. The cohort selection criteria were intentionally designed as such,
rather than an investigation of ARDS vs. healthy patients, to create a realistic repre-
sentation of the patient population and clinical settings where these algorithms would
be used. Because these data were acquired from hospitalized settings, the CXRs tend
to be more complex than a standard chest imaging obtained from controlled stud-
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Figure 3.1: Examples of chest x-rays from the Michigan Medicine dataset, annotated as
consistent with ARDS or inconsistent with ARDS based on the reviews of multiple clinical
experts. Chest x-rays (a), (b), (c) demonstrate the findings of ARDS, which are bilateral
airspace disease not explained by effusions, lobar/lung collapse, or nodules. These findings
may (b) or may not (a, c) be uniform across both lung fields. Chest x-rays (d), (e), (f) do
not demonstrate clear findings of ARDS, either because the lung fields lack clear airspace
disease (d) or the disease that is present is unilateral (e, f).
ies or outpatient settings. Characteristics of these complexities in the CXRs include
varying quality (e.g., dynamic range and sharpness), presence of introduced medical
devices, diverse body habitus, and manifestation of disease. Additional details about
the data used is provided in §3.4.1. Examples of CXRs in this dataset are depicted
in Figure 3.1.
3.3 Lung Segmentation of Complex Chest X-Rays
Lung segmentation, the process of accurately identifying regions and boundaries of
the lung field from surrounding thoracic tissue, is an essential first step in pulmonary
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image analysis of many clinical decision support systems. Correct identification of
lung fields enables further computational analysis of these anatomical regions [71],
such as extraction of clinically relevant features to train a machine learning algorithm
for detection of disease and abnormalities. These computational methodologies can
assist physicians with making a timely, accurate medical diagnosis to improve quality
of care and outcome for patients.
We therefore hypothesize that it may be possible to use image processing tech-
niques to handle heterogeneous characteristics of CXRs to facilitate better, more
generalizable lung segmentation. The aim of this study was to develop such an al-
gorithm capable of robust and reliable performance on multiple patient populations,
including critically ill patients. Our proposed hierarchical method first uses total
variation denoising to remove irrelevant details and artifacts from medical equipment
obscuring the lung fields. The image is then binarized with recursive thresholding to
identify the left and right lung fields. Finally, a stacked active contour model is used
to refine the final shape of the segmentation mask. The proposed method also incor-
porates systematic quality checks by using various assessment criteria at each step
to ensure consistent, successful segmentation. It is especially important that these
clinical decision support systems are highly reliable to ensure healthcare providers
that the algorithm will consistently perform as expected, even in the most rigorous
tasks. A deep learning approaching using U-Net, a convolutional neural network
(CNN) architecture designed for biomedical image segmentation [72], was included
as a “state-of-the-art” benchmark. A widely-used algorithm based on random walks
[73] and another established shape-based “active spline” model [74] were also included
for comparison with conventional image processing methods. These algorithms were
selected on the basis of having excellent performance results on publicly available
databases, being widely cited, and having an available codebase.
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3.3.1 Total Variation-based Active Contour
The proposed algorithm, Total Variation-based Active Contour (TVAC), is com-
prised of three primary steps:
1. Total variation denoising was employed to delineate and remove various medical
equipment visually obscuring the lung fields (§3.3.1.1).
2. Recursive binarization was used to systematically identify the lungs (§3.3.1.2).
3. A stacked active contour model was utilized to improve lung boundary formation
(§3.3.1.3).
Prior to execution, chest radiographs are first normalized with contrast-limited
adaptive histogram equalization (CLAHE) [75] to adjust contrast locally while lim-
iting the amplification of noise to ensure that CXRs in the dataset are generally
represented within the same pixel intensity range. A schematic diagram of TVAC is
provided in Figure 3.2.
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Schematic Diagram of TVAC
Visual Output of TVAC at Each Step
Figure 3.2: Outline of the proposed TVAC method. (a) An example image containing a
few wires from a patient diagnosed with acute hypoxic respiratory failure is shown. The
image is normalized with CLAHE at this step. (b) Total variation denoising is used to
diffuse wires while preserving edges of the lungs. (c) The denoised image is binarized
with recursive thresholding and initial lung segments are extracted. (d) Convex hulls are
generated from the extracted lung regions to enclose the lung fields and capture regions lost
during binarization. (e) Lungs are partitioned into quadrants, each is individually processed
with the stacked active contour model. (f) Final output of the lung segmentation algorithm.
Green represents the ground truth, magenta shows the algorithm’s segmentation output,
and white illustrates overlap of the two – indicating regions that are correctly segmented.
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3.3.1.1 Total Variation Denoising
Total Variation Denoising is a method to remove noise from images using a model
of Rudin, Osher and Fatemi (ROF) [76]. If f : Ω→ R is a a grayscale image, where












(f − u)2 (3.2)
Here λ is a regularization parameter. The level sets of an optimal solution u
have a small perimeter (relative to their area) (see for example [77, §2.2.2]). This
means that boundaries of the level sets tend to be smooth and round. ROF denoising
removes local details in images, while maintaining and smoothing the boundaries of
larger areas.
There are many algorithms for solving the optimization problem in the ROF
model. We use an algorithm and implementation of Zhu and Chan [78] that uses the
Primal-Dual Hybrid Gradient method (PDHG).
ROF denoising is used to remove irrelevant details and artifacts (e.g., electro-
cardiographic leads and prosthetic devices) from chest radiographs. Unlike blurring,
total variation denoising preserves sharp edges such as the boundary of the lungs.
The processed image retains most of the structurally large, well-defined regions of
the original image while removing unwanted objects of fine scale and discontinuous
variations. This workflow is illustrated in Figure 3.2a and 3.2b.
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3.3.1.2 Binarization with Recursive Thresholding
and Lung Field Identification
After denoising, the lung fields are localized through binarization of the image
with a recursive threshold. Binarization assumes that an image contains two classes
of pixels following a bi-modal distribution, where the foreground (region of interest)
and background pixels can be distinguished by finding an optimal threshold separating
the two classes. To determine this optimal threshold for global binarization, θk, the
Iterative Self-Organizing Data Analysis Technique (ISODATA) [79] is used.
First, the histogram is initially segmented into two parts using a starting threshold
(θ0) at half the maximum dynamic range. The mean of the values associated with
the foreground pixels (µf,θ0) and background pixels (µb,θ0) is calculated. An updated
threshold value θ1 is calculated as the average of these two sample means. This
method is repeated until the updated threshold value does not change anymore. This




until θk = θk−1 (3.3)
The denoised image is then binarized with threshold θk.
After binarization, morphological area opening is performed to remove small ob-
jects corresponding to artifacts from binarization. To extract the left lung, an object
whose centroid is nearest to the upper right half of the image is selected; to extract the
right lung, another object whose centroid is nearest to the upper left half of the image
is selected. The binary masks (regions containing the object of interest) extracted
from this process are shown in Figure 3.2c. Both objects are assessed for quality of
segmentation and similarity comparison, summarized in Algorithm 2, to ensure that
they accurately correspond to the two lung fields.
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Algorithm 2: Pseudocode for Binarization with Recursive Thresholding and
Lung Field Identification
Input : Denoised Chest X-Ray
1 calculate global threshold (θ0) with ISODATA
2 repeat
3 perform global binarization denoised image at threshold θ0
4 exclude artifacts > imageArea/4 and artifacts < imageArea/100
5 identify leftLung as the connected component with minimal Euclidean distance
from its centroid to the upper left half of the image; check for individual
assessment:
6 check Eccentricity > α
7 check Equivalent Diameter > β
8 check Filled Area > γ of total image
9 check Filled Area < δ of total image
10 check ROI is adjacent to image borders
11 identify rightLung as the connected component with minimal Euclidean distance
from its centroid to the upper right half of the image; check for individual
assessment:
12 check Eccentricity > α
13 check Equivalent Diameter > β
14 check Filled Area > γ of total image
15 check Filled Area < δ of total image
16 check ROI is adjacent to image borders
17 merge the two lung masks; check for similarity assessment:
18 check Major Axis Length > 1.5x of each other
19 check Convex Area > 13 of total image
20 if ≥ 2 failure from individual assessment and ≥ 1 failure from similarity
assessment then
21 θ0 = θ0 ∗ 0.95
22 until quality of segmentation is satisfactory ;
23 generate convex hulls from leftLung and rightLung
Output: convex hulls as binary masks for each lung
The parameters utilized in Algorithm 2 can be varied as needed to implement
this method for similar applications. The specific values used for this experiment are
provided in Table 3.1. These values generated reasonable results and demonstrated
robustness to variations in analysis. In particular, we increased and decreased these
values by 10% and observed that these changes did not have a significant impact on
the results. If the masks violate more than 1 of these criteria, threshold θk is reduced
by 5% and binarization is repeated. This process of recursively reducing threshold θk
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Although a wide range of parameters were tested, these are the specific values used in this
experiment. These values generated reasonable results and demonstrated robustness to variation
in analysis - even when the values were increased or decreased by 10%.
is repeated until all but one quality criteria are satisfied.
Convex hulls are then generated from both masks to enclose the lung fields. This
geometric representation of the lung fields, shown in Figure 3.2d, is the smallest
convex polygon shaped by vertices of the previous mask and is designed to capture
interior regions that weren’t included during binarization.
3.3.1.3 Stacked Active Contour Model
Following denoising and lung field segmentation the two convex hulls are then
further refined to better capture the shape of the lungs. A standard active contour
model (ACM) [80] is able to use these templates as a deformable spline, allowing the
convex hulls to “stretch” and better fit to the pleural lining of the lung. However,
we found that using the lung field as the template yielded unfavorable results and
incomplete segmentation, particularly with respect to the costophrenic recess and in
peripheral regions. To overcome this obstacle, we developed a stacked active contour
model where the lung quadrants, rather than the whole lung field, are used as tem-
plates to better capture these peripheral regions such as the apex and costophrenic
recess. Standard ACM uses a pre-defined number of consecutive iterations to ex-
pand or contract based on minimization of energy and other constraint forces. The
proposed ACM model sequentially “stacks” 50 iterations of parameterized contour
expansions, followed by 50 iterations of parameterized contractions. This process is
repeated 20 times, resulting in a total of 1000 iterations.
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The two masks from the upper and lower quadrants of each side are then combined
to reconstruct the lung fields. This final step is shown in Figure 3.3c and 3.3d for
reconstruction of the right lung field. A smoothing filter is applied to remove jagged
edges on the mask boundary.
Figure 3.3: Segmentation with the stacked active contour model. (a) An example source
image is shown for reference. (b) When the final segmentation mask is processed with
a standard active contour model, areas of incorrect segmentation can be systematically
observed – most commonly, at the right lung’s costophrenic recess and regions adjacent
to the diaphragm. (c) Quadrant-based processing with a stacked active contour model
shows better deformation and contouring to peripheral boundaries. (d) Final output for
segmentation of the right lung after combining the upper and lower quadrants and applying
a smoothing filter.
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3.3.2 Convolutional Neural Networks (U-Net)
U-Net is a convolutional neural network that was developed for biomedical image
segmentation [72]. For this study, we’ve trained the U-Net to perform lung segmen-
tation from CXRs. The network is based on the fully convolutional network and
its architecture was modified and extended to work with fewer training images and
to yield more precise segmentations. The U-Net CNN was implemented with Keras
[81] using the TensorFlow backend and trained on both the JSRT and Montgomery
datasets with 5-fold cross-validation. To further extend this analysis, additional ex-
periments were conducted with the U-Net trained on JSRT, Montgomery, and 50%
of Michigan Medicine data (including adult ARDS, adult severe ARDS, and pedi-
atric ARDS) to “fine-tune” the model so that it encounters an even greater variety
in patient population and heterogeneity of disease in the target dataset. Additional
details for these methods are published in previous works [72].
3.3.3 Random Walker
We used a modified implementation of the random walker algorithm designed for
unsupervised lung segmentation. This version relies on extracting horizontal intensity
profiles to intuitively match a pre-designed template to identify anatomical regions
of the CXR and accordingly place seed points for segmentation. First, the algorithm
proceeds by extracting 18 intensity profiles running horizontally, each of them equally
spacing apart, and in each intensity profile three extreme points denoting the two
lungs and the esophagus are determined through profile matching. The algorithm
removes profiles that do not intersect with the lung, and the rest of the extreme
points are plugged into random walker algorithm to perform segmentation. Additional
details for these methods are published in previous works [73].
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3.3.4 Active Spline Model
The active spline model used in this study is a combined point distribution model
and centripetal-parameterized Catmull-Rom spline for lung segmentation. This “tem-
plate matching” method uses a fixed set of points resembling a generalized shape of
the lungs and adapts this template to capture the lung fields from CXRs. After the
lung segmentation boundaries are generated, it can be easily edited to allow for users
to interact and refine the segmentation masks. Additional details for these methods
are published in previous works [74].
3.4 Application: Lung Segmentation from Complex CXRs
We evaluate the proposed TVAC method for lung segmentation on multiple data-
sets, including two publicly available CXR repositories and data from Michigan
Medicine comprising of critically ill patients with respiratory failure. Furthermore, we
compare the proposed algorithm’s performance to multiple state-of-the-art lung seg-
mentation methods, including a deep learning approach (§3.3.2), standard computer
vision algorithms (§3.3.3), and conventional image processing techniques (§3.3.4).
We used the Sørensen–Dice coefficient, a statistical validation method based on
spatial overlap to measure the degree of similarity between the algorithm’s segmenta-
tion and ground truth reference as annotated by multiple clinicians [82, 83]. Given two
sets X and Y representing the segmentation output and ground truth, respectively,
the Dice coefficient is defined as:
Dice(A,B) =
2TP
2TP + FP + FN
(3.4)
For this study, a Dice coefficient under 0.70 is recognized as failed lung segmen-
tation. This value is determined, through our experience from similar studies, as the
lowest acceptable level of segmentation correctness for effective feature extraction and
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sufficient for machine learning.
In addition to reporting summary statistics, we also present our experimental
results with a violin plot generated by a kernel density estimate of all the results
[84]. These plots are essentially mirrored density plots and enables a comparison of
algorithm performance, in terms of Dice coefficient, across patient populations. The
thicker part of a violin plot indicates higher frequency, and the thinner part implies
lower frequency. Violin plots with “longer tails” represent algorithms that more often
failed to accurately segment a patient’s lungs within a population.
3.4.1 Data
The Institutional Review Board approved this study with a waiver of informed
consent. We retrospectively identified three cohorts of patients hospitalized in adult
and pediatric intensive care units at Michigan Medicine in 2016 and 2017. The first
cohort was a random sample of 100 adult patients (mean age 58 years ± 16 [standard
deviation], 48% female) with acute hypoxic respiratory failure (PaO2/FiO2 ratio of <
300 mm Hg while receiving invasive mechanical ventilation), stratified such that 50
of the patients met the criteria for the Acute Respiratory Distress Syndrome (ARDS)
after review by clinical experts. The second cohort included chest radiographs from 25
additional adult patients (mean age 55 years ± 17 [standard deviation], 44% female)
with “high confidence ARDS” by multiple physicians [51]. Chest radiographs from
this cohort would be expected to have intense, widespread bilateral opacities that
would be more difficult for segmentation algorithms. The third cohort included 100
chest x-rays from pediatric patients (mean age 7 years ± 5 [standard deviation], 39%
female) hospitalized in the Pediatric Intensive Care Unit. Children age 14 days to 19
years with an endotracheal tube on mechanical ventilation were eligible for inclusion;
this cohort was stratified such that 50 of the patients met criteria for pediatric ARDS.
Additional details of these patient groups are provided in Table 3.2.
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Table 3.2: Patient demographic of Michigan Medicine cohort.
Adult Cohort Adult Severe ARDS Cohort Pediatric Cohort
n Age Non-ARDS ARDS n Age Non-ARDS ARDS n Age Non-ARDS ARDS
Total 100 58 ± 16 50 50 25 55 ± 17 0 25 100 7 ± 5 50 50
Male 52 60 ± 16 30 22 14 56 ± 16 0 14 61 9 ± 5 31 30
Female 48 64 ± 16 20 28 11 53 ± 19 0 11 39 6 ± 6 19 20
A total of 225 anterior-posterior chest radiographs were exported from Michigan
Medicine’s picture archiving and communication system then stored in the Digital
Imaging and Communications in Medicine format prior to analysis. Annotations for
ground truth of the lung regions on the two adult patient groups were performed by
a pulmonary critical care physician with 4 years of clinical experience. Annotations
for the pediatric cohort were performed by a pediatric critical care intensivist with 5
years of clinical experience.
CXRs from two publicly available datasets were also used to validate the algo-
rithm in other patient populations. The Japanese Society of Radiological Technology
(JSRT) [85, 86] is comprised of 247 posterior-anterior CXRs: 154 containing a pul-
monary lung nodule and the remaining 93 without any nodules. The second external
dataset from Montgomery County, made available by the U.S. National Library of
Medicine [87], contains 138 posterior-anterior CXRs: 58 are cases with manifestations
of tuberculosis and the remaining 80 are representative of normal, healthy lungs. A
summary of these patient groups is provided in Table 3.3.
Table 3.3: Patient demographic of JSRT and Montgomery datasets.
JSRT Montgomery
n Normal Abnormal n Normal Abnormal
Total 247 93 154 138 80 58
Male 119 n/a n/a 64 n/a n/a
Female 128 n/a n/a 74 n/a n/a
Individual patient age and gender information were not available for these two databases.
In the JSRT dataset, “abnormal’ refers to the presence of lung nodules. In the Mont-
gomery dataset, “abnormal” refers to the manifestation of tuberculosis.
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3.4.2 Results
Summary statistics of lung segmentation performance (mean, min, and standard
deviation of Dice coefficient) on the entire Michigan Medicine dataset, stratified by
different patient cohorts, from all four algorithms are reported in Table 3.4. The
results in Table 3.5 provide summary statistics from 50% of the Michigan Medicine
(held-out) dataset, when the other 50% is used for “fine-tuning” the U-Net algorithm.
Violin plots are also provided in Figure 3.5 to better visualize the distribution and
density of the reported results.

























TVAC 86.61 76.16 03.92 84.16 76.14 04.09 85.07 75.26 03.75
U-Net 88.85 00.01 11.77 84.82 43.32 11.81 87.32 56.45 08.53
Random Walker 74.46 14.97 18.82 64.63 15.96 16.19 67.31 18.92 17.78
Active Spline 64.01 20.03 16.70 62.29 15.83 15.83 61.37 14.91 17.60
Data are mean with minimum and standard deviation reported for each algorithm on different
patient populations. TVAC = Total Variation-based Active Contour, Dice = Sørensen–Dice
coefficient, ARDS = acute respiratory distress syndrome.
On all critically ill patient cohorts, TVAC and U-Net outperformed the random
walker and active spline model. Although the TVAC model and U-Net show com-
parable mean Dice coefficients, the TVAC algorithm maintained more consistency in
standard deviation and reliable performance (higher lowest Dice coefficient) across all
3 patient groups.
The TVAC algorithm was able to successfully segment lungs from CXRs of all
critically ill patient cohorts; the lowest Dice coefficient reported was 0.75 from the
pediatric cohort. Without fine-tuning, the U-Net has a total of 12 lung segmentation
failures from the entire Michigan Medicine test set: the algorithm was unable to
segment 4% of the adult cohort, 8% of the adult severe ARDS cohort, and 6% of the
pediatric cohort. With fine-tuning and exposure to a subset of Michigan Medicine’s
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data in its training set, the U-Net has a total of 12 lung segmentation failures from the
50% held-out test set: the algorithm was unable to segment 8% of the adult cohort,
15% of the adult severe ARDS cohort, and 12% of the pediatric cohort.
In comparison, the random walker algorithm was observed to have 83 unsuccessful
lung segmentations, failing 26% of the adult cohort, 44% of the adult severe ARDS
cohort, and 46% of the pediatric cohort. The most failures were observed from the
active spline model, which reported a total of 130 failures from 55% of the adult
cohort, 56% of the adult severe ARDS cohort, and 58% of the pediatric cohort.

























TVAC 86.08 77.90 04.39 83.01 76.14 04.23 84.67 78.27 03.64
U-Net 89.53 48.42 09.75 81.88 00.01 26.85 88.29 42.77 14.03
Random Walker 74.22 38.98 12.38 67.11 34.05 14.48 66.81 26.92 16.75
Active Spline 64.75 20.03 17.43 64.31 34.10 12.70 62.03 20.03 18.14
Data are mean with minimum and standard deviation reported for each algorithm on different
patient populations. TVAC = Total Variation-based Active Contour, Dice = Sørensen–Dice
coefficient, ARDS = acute respiratory distress syndrome.
In Figure 3.4, all four algorithms and their final lung segmentation from chest
x-rays of critically ill patients in the Michigan Medicine dataset are shown. These
examples were selected to present common pathological findings and characteristics
of more complex chest x-rays from hospitalized patients. These visually qualitative
results are presented to provide insight into the difficulty of this task and why these
algorithms may fail.
Nearly all segmentation methods performed well on lung fields that were clearly
defined, unobscured by medical equipment, and absent or with minimal manifestation
of any pathological conditions. In the presence of abnormalities, such as pulmonary
infiltrate in Figure 3.4a or lung opacities in Figure 3.4b, U-Net and the random walker
algorithm both failed to produce acceptable results on these examples. Patients
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Figure 3.4: Lung segmentation from CXRs of patients at Michigan Medicine. This fig-
ure illustrates the qualitative difference among algorithms and focuses on how they fail in
different clinical scenarios, including (a) manifestations of unilateral infiltrate (b) bilat-
eral lung opacities (c) extracorporeal abnormality from an unrelated comorbidity in the
abdomen (d) electrocardiographic leads overlying the lung fields (e) a prosthetic device
obscuring the outer boundary of the lungs and (f) a prosthetic device interfering with the
inner boundary of the lung.
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suffering from traumatic injury may also present with multiple abnormalities from
these comorbidities. An example of extracorporeal abnormality in the abdomen is
shown in Figure 3.4c. These types of issues may be problematic for deep learning
approaches, which are rigorously trained to identify a specific pattern representation
and may struggle when present with an unexpected example outside of what the
algorithm has been trained on.
The presence of medical equipment present throughout the chest x-ray is also
problematic. Figure 3.4d shows an example with electrocardiographic leads and wires,
which have visual characteristics comparable to the lung field boundaries (e.g., edges
that are well-defined, bright, and elongated). In this example, U-Net recognizes the
wires as an extension of the lung boundary and overextends the final segmentation
mask of the right lung field into the patient’s shoulder region. The random walker
algorithm identifies the wire as lung boundary and produces two lung segmentation
masks truncated at where the wires overlay the lung fields. Additional examples
of obscuring medical equipment are shown in Figure 3.4e and 3.4f, we observe that
both the random walker algorithm and active spline model fails for similar reasons as
previously mentioned.

















TVAC 95.01 84.88 02.97 95.69 85.66 02.51
U-Net 98.17 95.00 00.12 96.94 84.42 02.67
Random Walker 88.09 49.73 05.76 87.83 50.84 07.29
Active Spline 87.90 00.01 07.83 86.72 38.35 08.26
Data are mean with minimum and standard deviation reported for each algorithm on different
patient populations. TVAC = Total Variation-based Active Contour, Dice = Sørensen–Dice
coefficient, ARDS = acute respiratory distress syndrome.
Summary statistics of lung segmentation performance on both the JSRT and
Montgomery datasets from our proposed algorithm (TVAC), the U-Net CNN, Ran-
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Figure 3.5: Violin plot of segmentation results. Multiple patient cohorts and datasets from
Michigan Medicine were analyzed, including (a) the adult ARDS dataset, (b) the adult
ARDS dataset comprising of only severe cases, and (c) pediatric ARDS dataset.
dom Walker, and Active Spline Model are reported in Table 3.6. On these two datasets
containing standardized chest radiographs from previous studies, all four algorithms
perform relatively well. The U-Net CNN reports the best performance (Dice: 0.98
± 0.01 for JSRT, 0.97 ± 0.03 for Montgomery) of lung segmentation from these two
datasets, followed by our proposed TVAC method (Dice: 0.95 ± 0.03 for JSRT, 0.96
± 0.03 for Montgomery), the Random Walker algorithm (Dice: 0.88 ± 0.06 for JSRT,
0.88 ± 0.07 for Montgomery), and the Active Spline Model (Dice: 0.88 ± 0.08 for
JSRT, 0.87 ± 0.08 for JSRT).
3.5 Feature Extraction
After developing a robust method for lung segmentation, the next step in de-
tecting the presence of ARDS is to extract clinically meaningful features from the
region of interest (i.e., the lung fields). To do so, it is critical to investigate the lung
fields for pulmonary opacification – which manifests as a “cloud-like” appearance on
radiographs. We propose a method, Directional Blur, which aims to capture this in-
tuitive notion of diffuse alveolar injury and “cloudiness” as a mathematical concept.
The basis of this approach is to strongly blur along areas of the image that exhibits
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directionality and also in regions where there are few details. Artifacts and periph-
eral structures in the CXR (e.g., ribs, vasculature, medical equipment) typically have
features of directionality, while the detail-rich regions of the lungs and areas with
opacification do not. This approach enables quantification of lung injury by captur-
ing a diverse set of properties and measurements that may be suitable indicators for
ARDS.
In addition to Directional Blur, this study also examines other features that have
been used for similar applications in the detection of related lung diseases. For ex-
ample, first-order statistics calculated from the histogram are also included in this
work. These features have shown promising results in previously published works as
a textural descriptor to differentiate a healthy lung field compared to a CXR present
with lung injury [88]. Furthermore, we also extracted features from the gray-level
co-occurrence matrix (GLCM). These features characterize the texture of an image
by considering the spatial relationship and dependencies in the matrix. Although
features from the GLCM have been used to train machine learning models for detec-
tion of various lung diseases (e.g., pneumonia and atelectasis), we did not find any
research or studies applying GLCM features for detection of ARDS [89, 90, 91].
We also investigate the use of transfer learning with pretrained neural networks for
extracting additional features that can be used to train machine learning algorithms
to detect ARDS. Recent studies have indicated that information extracted from cer-
tain layers of convolutional neural networks can be very powerful features for use in
classification tasks [92]. For example, neurons in the first layer learn features similar
to Gabor filters while those from the last layer are more specific to the given learning
task [93]. Initializing a network with transferred features from different layers can
yield boosts to generalization even after fine-tuning to the target dataset [94]. Previ-
ously published works demonstrate this notion of transfer learning and document the
success of using these features extracted from intermediate and higher layers of CNNs
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for recognition tasks that the network was not trained on [94, 95, 96, 97]. Further-
more, this approach of using deep learning models trained on large scale, non-medical
data to extract features for general medical image recognition tasks via transfer learn-
ing has been demonstrated with favorable results by multiple research groups [98, 99].
Although several research groups have used pretrained networks to extract features
from CXRs, we are not aware of any studies that evaluate the feasibility of using
transfer learning in this capacity for detection of ARDS [89, 100].
3.5.1 Directional Blur
Lung infiltrates present with a “cloud-like” appearance on CXRs. We propose
Directional Blur, a novel method to capture the intuitive notion of cloudiness as a
mathematical concept. For this task, we first exclude normal findings within the CXR
– such as ribs, vasculature, and medical equipment (e.g., tubes, cables, prosthetic
devices). These artifacts typically have features of directionality, whereas the “clouds”
corresponding to lung opacities are non- directional. Therefore, a cloudy lung region
without artifacts can be described as follows: a) the average gray value will be above
a certain threshold, b) the gray level varies within the region, and c) the gray level is
non-directional.
Suppose that T : [0, a] × [0, b] −→ [0, 1] is a grayscale CXR. Consider a window
W = [u− ε, u+ ε] × [v − ε, v + ε] of size 2ε × 2ε about a point [u, v] in the lung





T 2xdx dy , Axy =
∫
W
TxTydx dy , Ayy =
∫
W
T 2y dx dy
then the function G : [0, a] × [0, b] −→ [0, 1] defined as G (u, v) =
√
Axx + Ayy
measures the variation in a region. We normalize G such that it has values in [0,1].
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is non-negative definite. Let λ1 < λ2 be the two eigenvalues of A, and define
H (u, v) = λ1
λ2
. Note that H has values between 0 and 1.
Our preliminary analysis and observation have shown that the product G ·H may
already be a suitable indicator for recognition of ARDS. The functions T,G,H, andG·
H applied to CXRs for a patient diagnosed with ARDS and for a non-ARDS patient
are shown in Figure 3.6a and 3.6b respectively. In both figures, the original CXR is
shown in the upper left, G in the lower left, H in the upper right, and G ·H in the
lower right.
First-order statistics and additional measurements, further described in §3.5.2,
are extracted from the product G · H as features to be used in training machine
learning algorithms for detection of ARDS. In total, 72 features were extracted from
Directional Blur.
3.5.2 Histogram
First-order statistics (mean, max, variance, kurtosis, and skewness) are calculated
from the CXR histogram to capture textural properties of the lung fields. Previ-
ously published literature has demonstrated that such features extracted from CXRs
exhibit significant differences between healthy and injured lung fields [88]. Specifi-
cally, higher variance and lower mean values in intensity have been observed in areas
with pulmonary opacities when compared to normal, healthy lungs [101]. This evi-
dence suggests that these first-order statistics correspond to the magnitude and the
coarseness (or fineness) of the infiltrate [102].
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Figure 3.6: Directional blur applied to CXRs. Output is shown (a) from a patient diagnosed
with ARDS and (b) from a non-ARDS diagnosis. The original CXR is shown in the upper
left, G in the lower left, H in the upper right, and G ·H in the lower right for both figures.
Additional measurements of the histogram are also used as features to capture
the density of pulmonary infiltrates by examining local grayscale distribution. These
features include standard deviation of the 5 largest local maxima (peaks), width of
the largest peak at half-prominence, gray-level value at the first and second largest
peaks, median of the maxima distribution and the frequency of that value, and area
under the histogram. Features were separately extracted from the lung fields and
lung quadrants. In total, 72 features were extracted from the histogram.
3.5.3 Gray-Level Co-Occurence Matrix
The gray-level co-occurrence matrix (GLCM) is a statistical method used to char-
acterize the texture of an image with respect to spatial relationships at the pixel
level [103]. The GLCM is defined as a two-dimensional matrix of joint probabilities
between pairs of pixels of co-occurring values at specified offsets, which is used to
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compute second-order statistics [104, 105]. Multiple offsets and angles can be defined
to increase the sensitivity of capturing pixel relationships of varying direction and
distance [90]. Statistics extracted from the GLCM have demonstrated promising re-
sults when used as features to train machine learning models for detection of various
lung diseases [89, 91, 106]. The second-order statistics extracted from the GLCMs in
this study are contrast, correlation, energy, and homogeneity.
Contrast measures local variation present in an image and returns a measure of
the intensity difference between a pixel and its neighbor over the entire image. For
example, a high value of this feature may indicate the presence of edges, noise, etc.
This property has been demonstrated to be higher in abnormal presentations within




where i and j represents the x and y coordinates of the GLCM and pi,j is the
element i, j of the GLCM.
Correlation measures the linear dependence (joint probability) of pixel pairs and
can be interpreted as quantifying the consistency of image textures. A high correlation
value indicates the predictability of pixel relationships. We expect that capturing
these characteristics of a CXR may be useful as features for this study. Correlation




Energy, also referred to as the angular second moment, measures the uniformity
of grayscale distribution of the image. Images with a smaller number of gray levels
(e.g., when it is considered very uniform in representation) have larger values of
energy. Therefore, we expect this measurement to be lower for abnormal findings and
useful for distinguishing between a CXR with an ARDS and one from a non-ARDS
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Homogeneity measures the closeness of the distribution of elements in the GLCM
to the GLCM diagonal and can be interpreted as a representation of the scale of local
changes in image texture. High values of homogeneity indicate the absence of intra-
regional changes and locally homogenous distribution of image textures. Homogeneity
is defined as ∑
i,j
pi,j
1 + (i− j)2
Features were separately extracted from the lung fields and lung quadrants for
each of the described GLCM properties. GLCMs are generated with multiple angles
(0°, 45°, 90° and 135°) at a pixel distance of 1. A single, “invariant” spatial direction
is generated by taking an average of the four directions so that the texture features
will not be influenced by the angle of rotation. A total of 24 features were extracted
from the GLCMs.
3.5.4 Deep Learning
A pretrained ResNet-50 deep learning model is used as to extract features from
chest x-ray scans for detection of ARDS. ResNet-50 is a deep convolutional neural net-
work consisting of 50 layers with skip connections to facilitate training deep networks,
specifically for optimizing trainable parameters during backpropagation to mitigate
the problem of vanishing gradients [108]. Residual networks such as ResNet50 are
composed of multiple building blocks with shortcut connections that skip convolu-
tional layers via identity mapping. Each block is composed of 3 convolutional layers
that perform downsampling with a stride of 2, followed by batch normalization and
rectified linear unit (ReLU) activation. The architecture of ResNet-50 ends with a
global average pooling (GAP) layer and a 1,000 fully connected layer with softmax
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activation. The network was trained on over a million images from the ImageNet
database [109] to learn rich feature representations and is capable of classifying into
1000 object categories.
Based on previously published work on transfer learning, we propagate CXRs (re-
sized to 244 × 244) through the pretrained network. These layers can be reinterpreted
as learned feature extraction layers [110] and activations from the GAP layer prior
to the fully connected layer are extracted as feature vectors that can be used to train
machine learning models to solve the classification task of this study. In total, 2048
features were extracted from the GAP layer of ResNet-50.
3.6 Application: Detection of ARDS from Complex CXRs
In this study, we evaluate these approaches - Directional Blur, first-order statis-
tics from the histogram, GLCM, and pretrained deep neural networks - on CXRs
obtained from Michigan Medicine and use the extracted features to train machine
learning models for the detection of ARDS. Support vector machine (SVM), ran-
dom forest, AdaBoost, and RUSBoost models were trained and evaluated with 5-fold
cross-validation on these features from 2018 CXRs (data from 70% of patients); the
final overall performance was then reported on a hold-out test set comprised of the
remaining 1060 CXRs (data from 30% of patients). To better understand the strength
and contribution of each technique, we present the results of classification when using
each feature set separately and also combining all features when training the machine
learning algorithms.
The extracted features were used to train multiple machine learning models for
the detection of ARDS. A soft-margin support vector machine (SVM) with a linear
kernel was used in this study and utilizes Bayesian optimization for tuning the C pa-
rameter (to adjust the penalty of misclassification). Random forest was implemented
with 300 decision trees – we determined this was optimal ntrees since it provided
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adequate model complexity and further increasing ntrees did not show a significant
difference in performance on the validation data. Gradient boosting has often been
compared to random forest given the number of similarities between the two tech-
niques. While random forest is known to be more robust to noise and easier to train,
boosting techniques maintain a reputation of being more resistant to overfitting, with
benchmark results having shown that booting produces better learners than random
forests. We implement adaptive boosting (AdaBoost) and random under-sampling
boosting (RUSBoost) in this work. Both techniques utilize Bayesian optimization to
tune the learning rate and number of learning cycles. Data from 70% of patients
(approximately 2018 CXRs) were used for model training and performance evaluated
using 5-fold cross-validation ong this training set. The final reported results are from
the remaining 30% of patients (1060 CXRs) that were used as the hold-out test set.
3.6.1 Data
This study was approved by the Institutional Review Board with a waiver of in-
formed consent. The patient cohort consists of adult patients hospitalized in intensive
care units at Michigan Medicine between 2016 and 2017. We retrospectively identified
patients with moderate hypoxia (requiring more than 3 L of supplemental oxygen by
nasal cannula for at least 2 hours) and acute hypoxic respiratory failure (PaO2/FiO2
ratio of < 300 mm Hg while receiving invasive mechanical ventilation).
In total, 500 patients were included in this study and 3078 anterior-posterior chest
x-rays were obtained. Of this population, 208 patients met the criteria for acute
respiratory distress syndrome after being reviewed independently by multiple clinical
experts. Labels for this dataset were generated using the same method described in
§2.4. Data from 70% of patients (approximately 2018 CXRs) were used for model
training and validation while the remaining 30% of patients (1060 CXRs) were used
as the hold-out test set. There are 191 females (mean age of 58 years, 32% ARDS
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Table 3.8: Cohort demographic for the Michigan Medicine ARDS CXR dataset.
n Age ARDS Non-ARDS
Male 151 57.16 ± 16.72 89 220
Female 349 58.46 ± 15.71 62 129
Total 500 57.65 ± 16.32 151 349
positive) and 309 males in this study cohort (mean age of 57 years, 29% ARDS
positive). The cohort demographics are summarized in Tables 3.7 and 3.8.
The chest x-rays in this study were reviewed independently by multiple clinical
experts to generate the labels used in training the machine learning algorithms. ARDS
is a life-threatening condition without a “gold standard” for diagnosis and the inter-
rate reliability for correct diagnosis of the illness is only moderate [8]. Because of
this, multiple experts were asked to determine whether each chest x-ray is consistent
with ARDS and also to provide a confidence level in their diagnosis as high, moderate,
slight, or equivocal. This information was converted to scale between 1-8 as illustrated
in Figure 2.6. If the clinical experts’ averaged review was below or equal to 4.5, a
label of -1 (no ARDS) would be assigned to the chest x-ray. If the averaged review
was above 4.5, a label of 1 (ARDS) would be assigned.
3.6.2 Results
CXRs are acquired in DICOM format and converted to an 8-bit grayscale image.
Lung segmentation was performed with TVAC (as described in §3.3.1) to identify
the region of interest from the CXR. Multiple masks were created for each CXR to
represent the two lung fields (e.g., left lung and right lung) and four lung quadrants
(e.g., upper-left lung and lower-left lung) to ensure that the extracted features meet
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one of the clinical criteria for diagnosis of ARDS (bilateral opacities on CXR).
Four distinct feature sets were used to train machine learning models for the de-
tection of ARDS from chest x-ray scans: Directional Blur, first-order statistics from
the histogram, information from a gray-level occurrence matrix, and deep learning
features extracted with a pre-trained neural network. Based on relevant works in an-
alytical morphomics, we perform a similar approach of normalization with structural
physiology (using a ratio of chest width to sternum width) for selected features [111].
Performance metrics (accuracy, Area under the Curve (AUC), and F1 score) on the
Michigan Medicine dataset for all four feature sets are reported in Table 3.9. The best
performance achieved using an individual feature set was attained with an AdaBoost
classifier trained on features derived from Directional Blur (0.78 accuracy and 0.74
AUC), followed by a RUSBoost classifier also trained on the same feature set (0.77
accuracy and 0.74 AUC). These results also indicate that training on multiple feature
sets can yield further improvements. The best overall performance was achieved
with AdaBoost trained on all available features from Directional Blur, first-order
statistics in the histogram, GLCM, and deep learning (0.83 accuracy and 0.79 AUC).
The second-best performing model when trained with all features is RUSBoost (0.81
accuracy and 0.77 AUC.) Results for additional permutations of combined features
(e.g., Directional Blur and histogram features) are provided in Table 3.10 and in the
supplementary materials (Table B.1, B.2, B.3).
Table 3.9: Performance metrics for detection of ARDS using features from Directional Blur,
the histogram, GLCM, and deep learning.




Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 73.31 66.58 58.91 70.83 62.60 57.97 72.47 65.62 59.79 73.34 67.90 64.85 74.63 73.70 64.24
Random Forest 75.97 66.80 56.28 73.86 64.64 54.36 74.98 65.70 54.63 75.91 65.76 59.47 76.81 71.22 63.43
AdaBoost 78.93 74.87 61.66 75.60 73.81 58.93 76.34 73.82 59.69 77.82 73.63 62.78 83.85 79.67 65.44
RUSBoost 77.68 74.78 65.90 74.62 71.55 64.62 77.70 72.12 66.38 77.88 72.46 63.93 81.03 77.68 67.29
Robust Boost 73.98 69.92 55.62 70.48 66.41 55.76 71.88 68.61 57.73 75.69 70.72 56.93 76.79 73.44 63.87
Total Boost 70.68 68.39 55.82 69.67 64.50 54.79 70.36 67.70 55.38 73.79 70.93 53.80 73.50 68.28 59.74
A total of 2216 features were used to generate these results: 72 features from
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Table 3.10: Additional performance metrics for classification results when using Directional






+ Deep Learning (ResNet-50)
All Features Combined
Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 73.53 68.97 59.70 74.36 69.80 62.87 75.90 70.61 64.75 74.28 73.09 64.75
Random Forest 75.87 66.63 59.74 76.90 68.32 59.64 76.72 67.64 62.80 76.78 71.36 63.91
AdaBoost 79.88 75.70 62.46 81.80 77.46 63.73 80.98 77.35 65.46 83.18 79.61 65.80
RUSBoost 77.84 73.46 62.73 79.47 76.82 66.16 80.70 76.83 65.70 81.66 77.31 67.45
Robust Boost 71.80 70.73 60.58 70.44 70.73 60.82 72.91 69.46 60.80 76.77 73.28 63.67
Total Boost 70.39 69.74 58.58 71.67 68.58 58.37 73.73 68.25 59.96 73.47 68.68 59.97
Directional Blur, 72 features from the histogram, 24 features from the GLCM, and
2048 features from deep learning. To reduce the dimensionality of utilized features, we
implemented feature selection with PCA, minimum redundancy maximum relevance
(mRMR), and chi-squared test. The first three principal components (98% of variance
explained) were used for the PCA approach. The top 100 most important predictors
were selected from feature selection with mRMR and chi-squared test. We did not
test beyond using the top 100 ranked features since anything beyond that yielded an
insubstantial predictor importance score. The results of this analysis are provided in
Table 3.11.








Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 74.82 73.69 64.31 73.88 67.39 62.44 70.76 66.98 61.71 79.73 74.20 59.47
Random Forest 76.23 71.88 63.91 74.73 65.44 53.09 75.76 67.41 62.82 79.60 73.91 61.70
AdaBoost 83.37 79.84 65.90 79.75 71.64 63.82 80.79 73.82 60.14 81.73 74.55 64.87
RUSBoost 81.79 77.80 67.57 76.64 68.71 58.23 76.92 72.52 62.57 80.96 76.80 65.43
Robust Boost 76.58 73.72 63.83 72.41 67.64 58.20 76.45 68.41 58.34 75.89 70.54 60.82
Total Boost 73.72 68.63 59.47 72.28 66.61 55.87 76.55 67.42 56.03 75.84 70.42 60.33
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3.7 Discussion
In this chapter, we developed a lung segmentation algorithm that would perform
well on both publicly available datasets from retrospective research studies and on
real-world data obtained from hospital and inpatient care, especially from critically
ill patients. We demonstrate that our TVAC algorithm is capable of accurate and
reliable lung segmentation from chest x-rays in the Michigan Medicine dataset com-
prising of hospitalized patients, of varying demographics and age groups, diagnosed
with moderate hypoxia, acute hypoxic respiratory failure, or ARDS. Furthermore, we
also evaluated TVAC on publicly available chest x-rays from the JSRT and Mont-
gomery datasets to benchmark our proposed method with multiple state-of-the-art
lung segmentation algorithms.
Many published algorithms and software platforms capable of lung segmentation
exist [61, 62, 63, 64, 65, 66, 67]. However, nearly all of them have only been evaluated
on chest radiographs where the lungs exhibit minimal or no pathological conditions
[112]. Segmentation of normal, healthy lungs can be fairly straightforward, as the
black pixels of the lung fields can be readily delineated from the white pixels of
peripheral anatomic regions [113]. This task becomes challenging when segmenting
lungs from chest x-rays of critically ill patients diagnosed with a lung disease or se-
vere condition, such as ARDS, pneumonia, and pulmonary edema. These injuries tend
to manifest with a white diffuse appearance [56, 114, 115] that may be incorrectly
recognized by many algorithms as regions outside the lungs, as these attenuating
characteristics are similar to the soft tissue of nearby anatomic structures. As a re-
sult, consolidation along the pleural margin of the lungs may generate an erroneous
delineation and incorrect segmentation. These complications are also present in re-
lated applications and orthogonal studies (e.g., detection of consolidation) involving
complex chest x-rays from hospitalized patients [70].
Furthermore, medical equipment such as wires, tubes, pacemakers, and various
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prosthetic devices can obscure lung fields on chest x-rays [68]. These objects are
characteristic of CXRs obtained from hospitalized patients or during inpatient care,
which may contain a diverse array of medical equipment used to monitor and treat
patients [116]. These items appear as connected regions of high pixel intensity with
strong edges, often interfering with edge detection of the lung’s pleural space and
resulting inaccurate boundaries. Because these objects don’t typically appear in
CXRs obtained from outpatient care or controlled studies, it is therefore essential
to include these types of complex data from clinical and hospital settings in the
evaluation set of any automatic lung segmentation algorithm. These physiological
abnormalities and noise from medical devices can hinder segmentation methods using
lung models that have been computed on healthy lungs only [117]. Because of this,
we also sought to investigate the efficacy and reliability of these algorithms on our
Michigan Medicine dataset.
Despite the high overall performance of the deep learning approach, our experi-
mental results demonstrate that U-Net can be inconsistent and suffers from numerous
lung segmentation failures. Based on the violin plots as well as results of segmenta-
tion on the JSRT and Montgomery datasets, we can infer that U-Net performs very
well on the types of x-rays it has encountered before. However, when new, unseen
examples of disease and noise are shown, the CNN is unable to generalize pattern
recognition for these challenging lung fields. Even when the U-Net is fine-tuned with
50% of all available Michigan Medicine so that it encounters an even greater variety
in patient population and heterogeneity of disease in the target dataset, the same
segmentation issues still persist - namely, failure to recognize the lung boundaries
due to interference from medical equipment or gross abnormalities present on the
image. These results suggest that although the U-Net is very capable of excellent
segmentation, robustness of the deep learning approach needs to be improved before
it is practical for clinical use.
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The “template matching” active spline model suffers from similar generalizability
issues as U-Net. On chest x-rays with well-defined lung boundaries, the algorithm is
capable of producing excellent masks. However, when lung fields and pleural regions
are obscured by injury (e.g. collapsed lung), the template matching attempt usually
fails [112, 118]. When developing TVAC, we also take into consideration the issues
of deployability, usability, and trustworthiness from the perspective of a healthcare
provider. Missing a few pixels is better than missing an entire lung field – especially
if the algorithm is extended and applied to subsequent clinical tasks (e.g., using
lung segmentation as a preprocessing step for prediction of acute respiratory distress
syndrome, pneumonia, or sepsis). Making a clinical decision based on inaccurate
information could be extremely dangerous for the patient’s outcome and we believe
that healthcare providers would likely opt for a more consistent system in lieu of one
with a slightly higher mean performance benchmark but less reliability.
We recognize that there are several limitations to this study. The cohort sample
sizes were relatively small, which limited the extent of stratified analysis, such as
looking at challenges in segmentation grouped by type of lung injury or in the pres-
ence of a specific treatment/medical device. Furthermore, due to the limited amount
of data available from Michigan Medicine, we were not able to train the U-Net on
this dataset. Therefore, the U-Net was trained on both the JSRT and Montgomery
datasets combined (evaluated with 5-fold cross validation) and we thus relied on trans-
fer learning for generalization of this CNN to the Michigan Medicine dataset. The use
of significantly larger training databases of CXR with heterogeneous characteristics
in future studies may improve the performance of the U-Net CNN. Another limitation
to note is that ground truth annotations of the lung fields were provided by critical
care physicians instead of radiologists. Although we don’t believe this has affected
our study, we do acknowledge that many similar studies involving ground truth from
radiographs typically relies on a radiologist, or the supervision of a radiologist, to
87
correctly annotate the image.
To extract features for detection of ARDS from complex CXRs, we propose and
describe Directional Blur, a novel feature engineering technique used to capture the
“cloud-like” appearance of diffuse alveolar damage as a mathematical concept. This
work also examines the effectiveness of using a pretrained deep neural network via
transfer learning as a feature extractor in addition to standard features extracted
from the histogram and GLCM.
Many published algorithms for the detection of various lung pathologies from chest
radiology exists [88, 89, 90, 91, 119, 102]. However, we did not find any studies that
particularly focused on acute respiratory distress syndrome. Some of these conditions
share similarities in pathology and clinical presentation, but it was unknown whether
the features used to detect a particular condition (e.g., sepsis) would also be effective
for the detection of ARDS. Our results show that some of these features do in fact
work, e.g., first-order statistics from the histogram and GLCM. Furthermore, we
demonstrate that the proposed Directional Blur technique is capable of detecting
ARDS and outperforms other techniques that have been used for similar applications.
We report that the best overall performance is obtained when the machine learning
models are trained with all four features sets combined rather than only having access
to each individual feature separately.
We also conducted extensive tests with several feature selection methods, includ-
ing principal component analysis (PCA), minimum reduction maximum relevance
(mRMR), and chi-squared test. The outcome of those experiments demonstrated
that better classification results were obtained when using all available features com-
pared to only using the most important features selected by these techniques. These
results were surprising at first, since we expected redundancy in the feature space,
especially from the 2048 features from deep learning. However, after a more com-
prehensive analysis the data, we concluded that this is reasonable because many of
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the tree-based and boosting methods already include feature selection in their im-
plementation. Therefore, models that don’t already include this process (e.g., SVM)
will benefit the most from feature selection – which is exactly what we observe in
Table 3.11 with SVM when using all available compared to only using the top ranked
features from the chi-squared test.
Although ResNet-50 was used to extract the deep learning features, a number
of other pretrained deep neural networks were also considered – including ResNet-
18, ResNet-101, Inception-v3, U-Net, and VGG19. These networks were primarily
chosen based on their publication record and capability in using arbitrary layers for
feature extraction. Preliminary results showed that features extracted with ResNet18,
ResNet101, and Inception-v3 did not perform as well as ResNet50. As the architec-
tures for U-Net and VGG19 do not contain a GAP layer features would be extracted
from the max pooling or convolutional layers. The activations from VGG19’s max
pooling layer have a dimensionality of 7 × 7 × 512, while the activations from U-Net’s
ReLU layer are of size 256 × 256 × 32, resulting in almost 2 million features when
flattened. We did try multiple tensor decomposition methods to work with this high-
dimensional data, including higher-order singular value decomposition (HOSVD), but
did not achieve satisfactory performance.
Intuitively, one could argue that the learned weights from the deeper layers should
be more specific to the images of the training dataset and the task it was initially
trained for. However, a number of publications have reported promising results with
features derived from the GAP layer. Furthermore, our internal testing showed com-
parable results between extracting features from the GAP layer and a shallower layer.
Ultimately, we decided to use ResNet-50’s GAP layer – which yielded 2048 features.
We recognize that there are several limitations to this study. With more data,
it would be worthwhile to investigate training an end-to-end deep learning model
directly from CXRs, comparing the effectiveness of this approach to features extracted
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with a pretrained deep neural network via transfer learning. Another limitation to
note is that our dataset is only labeled for binary classification of ARDS or non-
ARDS, even though the patients in the non-ARDS cohort still exhibit a degree of
respiratory failure. In future work, we would like to examine the feasibility of multi-
label classification to further improve accuracy in diagnosis. We also plan to include
additional data, such as signals from physiological waveforms and data from electronic
health records, for the detection of ARDS.
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CHAPTER IV
Learning Using Privileged Information
4.1 Introduction
The idea of using privileged information was first proposed by V. Vapnik and A.
Vashist in, in which they tried to capture the essence of teacher-student based learning
and knowledge transfer [120]. Standard machine learning paradigms consider the
following scenario: given a set of training examples, find, in a given set of functions,
the one that approximates the unknown decision rule in the best possible way. In
such a paradigm, the teacher does not play an important role.
Inspired by the way human learning works, they created a new learning paradigm
in which the learner is provided with not only a set of training examples, as described
above, but also a set of additional ”privileged information” that can help significantly
improve the learning process. Learning using privileged information (LUPI) acceler-
ates machine learning by more closely mimicking human teacher-student interactions.
In human interactions, the teacher provides the student with additional information
specific to each example, such as explanations. This allows the student to learn more
information from each example, thus learning faster and more effectively [121]. LUPI
considers the fact that while the privileged information are not available at the test-
ing stage, the abundance of such information in the training phase can help tune-up
and improve the choice of the solution fγ(x). This type of information is abundant in
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healthcare, where much more information about a patient’s health status is available
in retrospective databases compared to real-time environments.
In the LUPI architecture, at the training stage some additional information x∗i
about training example xi are available, while this privileged information will not be
available at the test stage. The LUPI paradigm can be formulated as follows: given a
set of training examples plus privileged information (xi, x
∗
i yi) , i = 1, . . . , N, in which
xi ∈ X form the input attributes/features, x∗i ∈ X∗ are the privileged information
on the training sample i, and yi ∈ {−1, 1} is the output class, the learning task is
to find a function fγ(x) : X → {−1, 1} (where γ ∈ Λ) to learn/generalize a mapping
between the input and the output considering the privileged information. Note that
the additional privileged information comes from the space X∗, which is different from
the space X and is not needed after the training phase, i.e. the learned function fγ(x)
does not need the privileged information to form predictions on the testing data. A
depiction of the LUPI paradigm is provided in Figure 4.1.
Figure 4.1: Depiction of the LUPI paradigm.
Specifically, in the training phase, a cost function defined over the training ex-
amples (that includes both the main input X and the privileged X∗ information) is
minimized to find the best set of parameters, γ, and therefore the solution fγ(x). In
LUPI the cost function is often composed of two sets of terms, one representing in
the error in mapping X to the output (as well as the complexity of the function) and
another set of terms representing in the error in mapping X∗ to the output (as well
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as the complexity of the function). Again, note that even though X∗ is included in
the optimization process in the training phase, the result of this optimization is fγ(x)
which is defined only over X.
LUPI has proven successful in several applications. Sharmanska et al. found that
learning using privileged information aided computer vision tasks [122]. Ribeiro et al.
found that SVM+, a modification of SVM that leverages privileged information, im-
proved bankruptcy prediction compared to regular SVM [123]. Liang et al. modified
SVM+ to handle multi-task learning and found that it proved more effective than
regular SVM [124].
This learning paradigm is highly useful for time-course predictive scenarios such
as clinical decisions making, in which the retrospectively training data sets contain
highly informative additional information that cannot be used by conventional ma-
chine learning. For instance, in the case of the early detection and prediction of
ARDS, while the conventional machine learning would only consider the features
extracted from clinical/physiological data for early detection of ARDS, i.e. the in-
formation in X, an LUPI paradigm can consider the available data, X, along with
the chest x-rays that are not available at the time of the actual decision making, i.e.
X∗. In other words, since the CXRs are available in the training datasets, they can
serve as the privileged information when creating the function fγ(x) that maps the
clinical/physiological data to the presence or absence of ARDS, i.e. {-1,1}.
In this project, we implement the LUPI paradigm in several machine learning
models for detection patients with ARDS. This initial study uses CXR ratings by
clinicians as privileged information. Chapter V provides in-depth details on the opti-
mization algorithms, extension for partially available information, and incorporation
with label uncertainty with feature extraction methods as described in §3.5.
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4.2 Implementation with Support Vector Machines (SVM+)
The formulation of LUPI for SVM, called SVM+ is provided here. Given a set of
training data pairs:
(x1, y1) , . . . , (xn, yn) xi ∈ X, yi ∈ {−1, 1}
“Standard” SVM first maps training data vector x ∈ X into vector z ∈ Z where it
constructs the optimal separating hyperplane by learning the decision rule f (z) =







s.t. ∀1 ≤ i ≤ n, yi (w · zi + b) ≥ 1− ξi
∀1 ≤ i ≤ n, ξi ≥ 0
(4.1)
where C > 0 is a hyperparameter.
In the LUPI paradigm, the set of training data triplets are:
(x1,x
∗
1, y1) , . . . , (xn,x
∗
n, yn) xi ∈ X,x∗i ∈ X∗ yi ∈ {−1, 1}
where x∗i is the privileged information. Let z
∗
i be a feature map of x
∗
i . The SVM
formulation for LUPI, i.e. SVM+, can be thought of as the classical SVM with the
same decision function f(z) = w ·z+b but a correcting function, ϕ (z∗) = w∗ ·z∗+b∗,
in lieu of the slack variables. Then the decision rule and the correcting function










∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ n, yi (w · zi + b) ≥ 1− (w∗ · z∗i + b∗)
∀1 ≤ i ≤ n,w∗ · z∗i + b∗ ≥ 0
(4.2)
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where C > 0 and γ > 0 are hyperparameters. Note that γ
2
‖w∗‖22 restricts the
VC-dimension of the correcting function space. As implied in [11], replacing the slack
variables with the smooth correcting function ϕ (z∗) = w∗ · z∗ + b∗ may not always
be the best choice. Instead we can use a mixture of slacks as:
ξ′i = (w
∗ · z∗i + b∗) + ρξ∗i ∀1 ≤ i ≤ n (4.3)















∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ n, yi (w · zi + b) ≥ 1− (w∗ · z∗i + b∗)− ξ∗i
∀1 ≤ i ≤ n,w∗ · z∗i + b∗ ≥ 0 ξ∗i ≥ 0
(4.4)
where C = ρC∗. If C  C∗ (i.e. ρ  1 ) this problem behaves similar to (4.4),
and if C  C∗ (i.e. 0 < ρ 1 ) it converges to the solution of the conventional SVM
with soft-margin (4.1). The dual optimization problem of 4.4 is further discussed in
§5.2.
4.3 Implementation with Decision Trees
The proposed method for implementation of LUPI with decision trees is called
iterative privileged learning. In the gradient step that is used from step t− 1 to step
t, auxiliary variables are introduced. These encode the privileged information. In
other words, auxiliary functions are generated that gives an output corresponding to
privileged information.
We want to use a quadratic loss function to determine the “discrepancy” between
the label predicted by the model at an iteration t, and the ground truth labels. We
use an approach implementing the LUPI method in the theory of Gradient Boosted
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Decision Trees (GBDT) [125], modifying the loss function to incorporate privileged
information.
Suppose our dataset consists of triplets (xi, x∗i, yi) , where xi and x∗i are vectors
with real entries (possibly different lengths, since the number of privileged features
might be different from the number of non-privileged features), and yi are the ground
truth labels. In standard GBDT, the loss function used to update the decision trees






Where Gt (xi) is the decision function at step t, evaluated on the vector xi. At the
subsequent step of the algorithm, Gt is updated by Gt + ht, where the latter term is
a ”small” tree that perturbs the one obtained at step t. The new perturbing decision
tree can be determined by minimizing quantity:
∑
[ht (xi)− (Gt (xi)− yi)]2
over all small trees (for some fixed number of nodes etc.). GBDT with privi-
leged information includes an additional term that takes into account the privileged
information, corresponding to:
∑
C [ht (xi)− (Gt (xi)− yi)− wtxi]2
for real numbers wt that vary during the learning process.
The change of wt has the meaning of an adjustment of the teacher’s instructions
during the learning process, which has quite an intuitive meaning as compared to
human learning. The number C is a hyper-parameter whose optimal value is set
to be determined during cross-validation. We implement the LUPI methodology by
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including a mixture of slack variables, µi, µ
∗
i and a · µ∗ + b. The coefficients a are
updated during learning process, in analogy to the update of wt, whose significance
was previously pointed out. The objective function to minimize is therefore given by:
min
∑
[ht (xi) − (Gt (xi)− yi)]2 +
∑
t
C [ht (xi)− (Gt (xi)− yi)− wtxi]2
+C ′µi + C
′′µi ∗+C ′′′(a · µ ∗+b)
4.4 Application
In this project, we implement the LUPI paradigm in several machine learning
models for detection patients with ARDS. This initial study uses CXR ratings by
clinicians as privileged information and features previously described in §2.5.1 and
Appendix A. This initial study attempts to address the issue of unreliable data
and using the LUPI paradigm to incorporate additional data available during model
training but not accessible during testing.
4.4.1 Data
The ARDS dataset used in this study consisted of 485 patients with either moder-
ate hypoxia or acute hypoxic respiratory failure, treated at the University of Michigan
Hospital. We received institutional review board from the University of Michigan to
collect data for the study (HUM00104714) with a waiver of informed consent among
study participants. Each case was independently reviewed by multiple expert clini-
cians for the diagnosis of ARDS; the labels for this dataset were generated using the
same method described in §2.4. Multiple experts reviewed the cases as there can be
disagreement between doctors reviewing the same patients for the diagnosis of ARDS
[11]. Clinical experts also identified the time of ARDS onset for those patients who
were deemed to have developed the condition. Patients who developed ARDS were
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labeled as negative before the time of onset and positive for ARDS after.
The non-privileged information consisted of 25 clinical variables (features) ex-
tracted at two-hour intervals from the patient’s EHR. The clinical features are pro-
vided in Appendix A. Privileged information for each patient consisted of the average
of scores among multiple clinical experts reviewing CXRs performed during the hos-
pitalization. Each clinician gave each CXR a rating of 1− 8, scoring their belief that
the x-ray was consistent with ARDS (8 for high-confidence ARDS and 1 for high-
confidence non-ARDS). As such, privileged information is the average of these scores
if the CXRis available.
In the experiment for classifying ARDS, the dataset was first split into training
and testing sets as shown in Figure 4.2. In order to avoid bias toward patients,
all samples from the same patient were kept exclusively in either training or testing.
This yielded 323 patients in the training dataset, and the rest in the testing set. Also,
due to the strong inter-dependency between samples of longitudinal patient data, the
IID (independent and identically distributed) assumption was invalid. Therefore,
the time-series sampling method proposed in §2.2.2 was performed to reduce inter-
correlation among the longitudinal clinical data from each patient used in model
training. After sampling, there were 4661 samples in the training dataset, with 1298
positive for ARDS. Since there was no sampling in the testing dataset, there were
9362 samples in the test dataset.
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Figure 4.2: Flowchart of the study protocol. 5-fold cross-validation was performed as
suggested in §2.2.2 and hyperparameter optimization was implemented with grid search.
4.4.2 Results
Table 4.1 summarizes the preliminary results of this experiment. We report that
SVM+ achieves an AUROC of 69.85 on the hold-out test set, outperforming standard
SVM by 13.9%. Similarly, we observe that DT+ achieves an AUROC of 67.05 and
outperforms standard DT by 8.04%.






SVM 69.85 55.23 77.90
SVM+ 79.61 67.88 91.41
DT 67.05 50.30 73.58
DT+ 72.44 64.91 88.47
SVM = support vector machine, SVM+ = LUPI implementation of support vector machine,
DT = decision trees, DT+ = LUPI implementation of decision trees.
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4.5 Discussion
This preliminary study demonstrates the capability of LUPI-based machine learn-
ing models for clinical applications and serves as the foundation for future works pre-
sented in Chapter V. From these initial experiments, we gained intuition for how to
use LUPI in practical scenarios and for how to improve on the existing paradigm.
In this work, the models utilized CXR ratings by clinicians as privileged infor-
mation. However, in an actual production environment, it may not be the feasible
for physicians to rate each CXR in order to assist with generating the privileged in-
formation used by SVM+. A future direction for this research would be to use the
methods developed in Chapters II and III to build a fully automated ARDS detection
system. In other words, we propose that the previously described lung segmentation
method (§3.3.1) and features extracted from the CXRs (§3.5) can serve as the privi-
leged information used in the LUPI models while using the routinely collected EHR
data can continue to be used as the standard training feature space.
One addition limitation of LUPI that hasn’t been discussed yet is the fact that
this learning paradigm assumes that privileged information is available for all train-
ing samples during parameter estimation. This motivates us to consider additional
modification to the LUPI framework to encode such partial availability of privileged
information in the training set. Based on the results presented in Table 4.1, it seems
intuitive to move forward with further development of the LUPI framework with an
SVM-based model. In Chapter V, we present a re-formulation the SVM model to




Learning Using Label Uncertainty and Partially
Available Privileged Information
5.1 Introduction
In developing the LUPI-based machine learing models for detection of ARDS,
it is important to recognize that privileged information (CXRs) are sometimes only
available for a portion of the training data. In other words - not every patient receives
an CXR, however, the LUPI paradigm assumes that privileged information is available
for all training samples during parameter estimation.
Building from LUPI framework previously described in in Chapter V, we will
proposed a learning scheme that provides the capabilities of both learning from un-
certain labels and learning using “partially available” privileged information to create
a methodology that would better match the clinical reality of ARDS detection and
many other healthcare problems. The proposed frameworks use EHR data as reg-
ular information, CXRs as partially available privileged information, and clinicians’
confidence levels in ARDS diagnosis as a measure of label uncertainty.
We first describe our proposed learning from uncertain labels using privileged in-
formation (LULUPI) at a general level and then customize the model towards SVM,
whose formulation make the design of such specialized learning paradigms more in-
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sightful. In the LULUPI formulation, training examples with uncertain labels and
privileged information are available:
1. A subset of data with certain labels, i.e. (xi, x
∗
i , yi) , i = 1, . . . , N1, in which
xi ∈ X form the input features, x∗i ∈ X∗ are the privileged information on the
training sample ui′′, and yi ∈ {−1, 1} is the output class.
2. A subset of data with uncertain labels, i.e. (xi, x
∗
i , yi, li) , i = N1 + 1, N1 +
2, . . . , N , in which xi ∈ X, x∗i ∈ X∗, yi ∈ {−1, 1} and 0 < li ≤ 1 is the level of
confidence (i.e. lack of uncertainty) over sample i.
In LULUPI, the learning task involves minimizing the cost function that includes
four sets of terms:
1. Terms representing in the error in mapping X to the output (as well as the
complexity of the function) for data with no uncertainty,
2. Terms representing in the error in mapping X to the output (as well as the
complexity of the function) for data with uncertainty,
3. Terms representing in the error in mapping X∗ to the output (as well as the
complexity of the function) for data with no uncertainty,
4. Terms representing in the error in mapping X∗ to the output (as well as the
complexity of the function) for data with uncertainty.
Another improvement considered here is to incorporate privilege information with
label uncertainty, since there are many real-world machine learning scenarios in which
the simultaneous use of privileged information and label uncertainty have the poten-
tial to improve model performance. Motivated by the potential benefit for such
an integration into a unified paradigm, label uncertainty is incorporated into the
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LUPAPI paradigm and attendant SVMp+ formulation, resulting in a general frame-
work of learning using label uncertainty and partially available privileged information
(LULUPAPI). A depiction of the LUPAPI paradigm is provided in Figure 5.1.
Figure 5.1: Comparison of LUPI and LUPAPI paradigms.
As there are multiple ways in which to incorporate partially available privileged
information into SVM, three models are considered:
1. Vapnik’s model [120], a natural extension of SVM+.
2. The mixture model, an SVMp+ formulation with a mixture of slack variables
and a correcting function.
3. The symmetric mixture model, an SVMp+ formulation with a mixture of slack
variables and a correcting function with label coefficients.
The end of this section describes how label uncertainty can be integrated into the
SVMp+ formulation (LULUPAPI).
5.2 Implementation with Support Vector Machines (SVM+)
5.2.1 Vapnik’s Model: An Initial Model for Partial Availability of Privi-
leged Information
Fundamentally, the problem of partial availability of privileged information can
be addressed using a combination of the classical SVM and standard SVM+. In other
words, one can consider slack variables for the samples without privileged information
103
and the correcting function for the samples with privileged information. This model
was proposed by Vapnik et al. [120] within the LUPI framework, but not explored
further.
Suppose the training data has m samples with privileged information and n−m
samples without privileged information:
(x1,x
∗
1, y1) , . . . , (xm,x
∗
m, ym) , (xm+1, ym+1) , . . . , (xn, yn)
xi ∈ X,x∗i ∈ X∗, yi ∈ {−1, 1}
The decision rule, the slack variables, and the correcting function hyperplane param-













∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ m yi (w · zi + b) ≥ 1− (w∗ · z∗i + b∗)
∀1 ≤ i ≤ m w∗ · z∗i + b∗ ≥ 0
∀m+ 1 ≤ i ≤ n yi (w · zi + b) ≥ 1− ξi
∀m+ 1 ≤ i ≤ n ξi ≥ 0
(5.1)
where C > 0, C∗ > 0, and γ > 0 are the hyperparameters. This cost function is the
most natural extension of the LUPI model. The dual optimization problem of (5.1)











i,j=1 (αi + βi − C∗) (αj + βj − C∗)K∗i,j
s.t.
∑n
i=1 yiαi = 0∑m
i=1 (αi + βi − C∗) = 0
∀m+ 1 ≤ i ≤ n, 0 ≤ αi ≤ C
∀1 ≤ i ≤ m, 0 ≤ αi, 0 ≤ βi
(5.2)
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where K∗i,j , K
∗ (z∗i , z∗j) is a kernel in the correcting space and Ki,j , K (zi, zj) is
the kernel in the decision space with the decision function:
f(z) = w · z + b =
n∑
i=1
yiαiK (zi, z) + b. (5.3)
Since the aforementioned Vapnik’s model was never explored further, in this paper
an optimization procedure was also developed and tested for this formulation.
5.2.2 The Proposed LUPAPI Framework: SVMp+ Formulations
In this section, two realizations of the SVMp+ formulation of LUPAPI are pro-
vided: the mixture model and the symmetric mixture model.
5.2.2.1 Mixture Model
This formulation of SVMp+ can be thought of as SVM+ with the mixture model
of slacks as:
ξ′i = (w
∗ · z∗i + b∗) + ρξ∗i ∀1 ≤ i ≤ n (5.4)
In this case, the slack variables are considered for all training samples, and the
correcting function only for those samples with privileged information. The deci-
sion rule, the slack variables, and the correcting function hyperplane parameters are
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∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ m yi (w · zi + b) ≥ 1− (w∗ · z∗i + b∗)− ξ∗i
∀1 ≤ i ≤ m w∗ · z∗i + b∗ ≥ 0
∀1 ≤ i ≤ m ξ∗i ≥ 0
∀m+ 1 ≤ i ≤ n yi (w · zi + b) ≥ 1− ξi
∀m+ 1 ≤ i ≤ n ξi ≥ 0
(5.5)











i,j=1 (αi + βi − C∗) (αj + βj − C∗)K∗i,j
s.t.
∑n
i=1 yiαi = 0∑m
i=1 (αi + βi − C∗) = 0
∀m+ 1 ≤ i ≤ n, 0 ≤ αi ≤ C
∀1 ≤ i ≤ m, 0 ≤ αi ≤ ρC∗, 0 ≤ βi
(5.6)
5.2.2.2 Symmetric Mixture Model
In this model, the goal is to better transfer the knowledge obtained in the privi-
leged information space to the decision space by allowing the privileged information
and the training label to interact, as suggested in [121]. Instead of the mixture model
of slacks in (5.4), consider the following mixture for the LUPAPI model:
ξ′i = yi (w
∗ · z∗i + b∗) + ρξ∗i ∀1 ≤ i ≤ m (5.7)


















∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ m yi (w · zi + b) ≥ 1− yi (w∗ · z∗i + b∗)− ξ∗i
∀1 ≤ i ≤ m yi (w∗ · z∗i + b∗) ≥ 0
∀1 ≤ i ≤ m ξ∗i ≥ 0
∀m+ 1 ≤ i ≤ n yi (w · zi + b) ≥ 1− ξi
∀m+ 1 ≤ i ≤ n ξi ≥ 0
(5.8)











i,j=1 (αi + βi − C∗) (αj + βj − C∗) yiyjK∗i,j
s.t.
∑n
i=1 yiαi = 0
∀m+ 1 ≤ i ≤ n, 0 ≤ αi ≤ C∑m
i=1 yi (αi + βi − C∗) = 0
∀m+ 1 ≤ i ≤ m, 0 ≤ αi ≤ ρC∗, 0 ≤ βi
(5.9)
This model is referred to as symmetric because the yi coefficients are considered for
the hyperplane in the privileged space as well. This model differs from that proposed
[121] in two ways - it incorporates partially available privileged information and allows
for two separate sets of slack variables for the training and privileged spaces.
5.2.2.3 LULUPAPI: Incorporating Label Uncertainty within the SVMp+
Formulations
In this section, label uncertainty is integrated into the SVMp+ formulation of LU-
PAPI, yielding the Learning Using Label Uncertainty and Partially Available Privi-
leged Information (LULUPAPI) model. To avoid repetition, only the mixture model
of LUPAPI (described in §5.2.2) is considered. In order to incorporate label un-
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certainty, one can vary the parameter C for training samples in proportion to their
respective label confidence.
As the slack variables ξi (or the correcting function) permit some misclassification
with penalty parameter C to establish soft-margin decision boundaries, data with high
label confidence can be given more weight and subsequent influence on the decision
boundary. This yields the LULUPAPI paradigm, which requires the training samples:
(x1,x
∗
1, y1, π1) , . . . , (xm,x
∗
m, ym, πm) , (xm+1, ym+1, πm+1)
(xm+2, ym+2, πm+2) , . . . , (xn, yn, πn)
xi ∈ X,x∗i ∈ X∗, yi ∈ {−1, 1}, πi ≥ 0
where πi is a quantitative measure of uncertainty in the labels. In this case, the

















∗ · z∗i + b∗)
s.t. ∀1 ≤ i ≤ m yi (w · zi + b) ≥ 1− yi (w∗ · z∗i + b∗)− ξ∗i
∀1 ≤ i ≤ m yi (w∗ · z∗i + b∗) ≥ 0
∀1 ≤ i ≤ m ξ∗i ≥ 0
∀m+ 1 ≤ i ≤ n yi (w · zi + b) ≥ 1− ξi
∀m+ 1 ≤ i ≤ n ξi ≥ 0
(5.10)











i,j=1 (αi + βi − C∗) (αj + βj − C∗)K∗i,j
s.t.
∑n
i=1 yiαi = 0∑m
i=1 (αi + βi − C∗) = 0
∀1 ≤ i ≤ m, 0 ≤ αi ≤ ρπiC∗, 0 ≤ βi
(5.11)
108
5.2.3 An Alternating SMO Algorithm for SVMp+ Formulations of LU-
PAPI and LULUPAPI Paradigms
A widely used algorithm for solving conventional SVM and SVM+ is Sequential
Minimal Optimization (SMO) [126]. SMO-style algorithms iteratively maximize the
dual cost function by selecting the best maximally sparse feasible direction in each
iteration and updating the corresponding αi and βj such that the dual constraints
are also satisfied.
A variant of SMO called Alternating SMO for solving SVM+ was previously in-
troduced Pechyony et at. [127, 128]. Inspired by this optimization method, an alter-
nating SMO-style algorithm for SVMp+ is proposed. The SVMp+ dual optimization




where θ ∈ Rk, D : Rk → R is a concave quadratic function, and F is a convex
compact set defined by linear equalities and inequalities.
In order to achieve an alternating SMO algorithm for SVMp+, all feasible direc-
tions for each model must be determined. Feasible and maximally sparse feasible
directions were defined in [127] as follows:
Definition 1. A direction u ∈ Rk is feasible at the point θ ∈ F if there exists λ > 0
such that θ + λu ∈ F .
Definition 2. A direction u1 ∈ Rk with n1 < k zero elements is maximally sparse
feasible if any u2 ∈ Rk with n2 < k zero elements such that n1 < n2
is not feasible.
The cost function in equations (5.2), (5.6), (5.9), and (5.11) have n+m variables:
{αi}ni=1 and {βi}
m
i=1 . These can be combined into a single (n + m) variable vector θ
by concatenating the α and β variables: θ , (α,β)T . Thus, each maximally sparse
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feasible direction is u ∈ Rn+m. It can be verified that the cost functions in equations
(5.2), (5.6), and (5.11) have 9 sets of such directions, and (5.9) has 10. Following [127],
each set of feasible directions is denoted by Ii. The detailed descriptions of the feasible
directions and other optimization information for Vapnik’s model (5.2), the mixture
model (5.6), the symmetric mixture model (5.9), and the LULUPAPI mixture model
(5.11) formulations can be found in Appendices C, D, E, and F, respectively.
5.2.3.1 Optimization Process
Similar to the SMO algorithm for the LUPI model [127, 128], the recursive step in
the proposed optimization for the LUPAPI and LULUPAPI paradigms is finding θ =
θold + λ∗(s)us such that us ∈ ∪Ii of the corresponding feasible directions and the step





satisfying the constraints. Hence, given the cost function, its constraints, and the
corresponding feasible directions, the recursive optimization process of the proposed






and H respectively be the gradient at point θold and the Hessian of






























I = ∅, then the algorithm stops. Suppose I 6= ∅, define:
Ĩi =
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Among all the possible directions from us′(i) ∈ ∪Ĩi, the optimal direction that
maximizes the cost function is chosen:

















clipped such that it satisfies the upper/lower bound constraints on {αi}ni=1 and
{βi}mi=1 . Clipping functions are specific to the dual problems of each SVMp+ for-
111
mulation and can be found in the Appendices C, D, E, and F.
5.2.3.2 Algorithm
Having described the framework for the proposed alternating SMO-style algorithm
that solves the SVMp+ dual cost functions of the LUPAPI and LULUPAPI models,
the resultant algorithm is codified in Algorithm 3. Note that most of the calculations
for Ii can be performed once, rather than in each iteration, as they depend largely on
the label and indices of the training data samples. One can consider various initial
conditions for the α and β variables. Since the feasible directions and clipping function
ensure the satisfaction of the dual problem conditions, a satisfactory initial condition
guarantees the fulfillment of these conditions in each iteration. In all variants of the
LUPAPI and LULUPAPI models, the simplest initial condition that satisfies all of
the constraints is α
(0)




Algorithm 3: Alternating SMO-style Optimization for SVMp+
formulations of LUPAPI and LULUPAPI
Require: Training data, training labels, τ > 0, γ > 0, C > 0, C∗ > 0, and 0 < ε 1.











3 Initialize: Ii for each feasible direction based on the indexes and training labels.
4 while exists a maximally sparse feasible direction us s.t. g (θ






5 θold = θnew
6 Calculate g(θold)
7 Update Ii for all i based on θ
old
8 Calculate Ĩi if Ii 6= ∅
9 Calculate s(i) if Ĩi 6= ∅ using (5.12)
10 Calculate s′(i) if Ĩi 6= ∅ using (5.13) or (5.14)
11 Calculate s∗(i) if ∪Ĩi 6= ∅ using (5.15) Calculate λ∗ using the corresponding
clipping function
12 Update θnew = θold + λ∗us∗
As previously mentioned, while the proposed optimization process for the LUPAPI
and LULUPAPI models is the same given the dual cost function and the corresponding
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Figure 5.2: Alternating SMO-style optimizer for the LULUPAPI model.
feasible directions, the LULUPAPI model is always the most comprehensive model
and any given algorithm for LULUPAPI can easily be modified to realize a LUPAPI
version. For instance, any algorithm specifically designed for the LULUPAPI mixture
model can be made into a LUPAPI mixture model by simply replacing the uncertainty
coefficients with unity. A general schematic diagram of the LULUPAPI iterative
optimizer is depicted in Figure 5.2.
5.3 Application
In this work, a unified framework for handling machine learning tasks in which
privileged learning is partially available is presented, while simultaneously correcting
for label uncertainty. As there are multiple means of incorporating partially available
privileged information into SVM, three models were considered: Vapnik’s model [120];
and two new SVMp+ formulations, the mixture and symmetric mixture models. An
alternating SMO-style optimization algorithm was provided that solves all model
formulations.
We implement the proposed LUPAPI and LULUPAPI paradigm in several ma-
chine learning models for detection patients with ARDS. The proposed frameworks
use EHR data as standard information, CXRs as partially available privileged in-
formation, and clinicians’ confidence levels in ARDS diagnosis as a measure of label
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uncertainty.
Unlike the previous study in Chapter IV that relied on CXR ratings from physi-
cians, this work uses feature extracted from the CXR as the privileged information.
As previously described, lung segmentation is performed with TVAC (§3.3.1) and fea-
tures are extracted from the lung fields. In this work, the extracted features are ob-
tained from Directional Blur (§3.5.1), the histogram (§3.5.2), gray-level co-occurence
matrix (§3.5.3), and deep learning (§3.5.4).
5.3.1 Data
This work uses the same dataset as previously described in §2.5.1 and §3.6.1.
5.3.2 Results
For the ARDS dataset in the previous section, a LUPAPI or LULUPAPI formu-
lation was the best performing model. In the LUPAPI experiments on the ARDS
dataset as depicted in Table 5.1, the mixture model was the best performing model,
achieving an AUC of 85.78%, a 2.8% improvement over SVM. Using the same mixture
model, but incorporating label uncertainty, the LULUPAPI formulation in Table 5.2
achieved an AUC of 87.01%, a 4.3% improvement over SVM. The statistical tests in
Table 5.3 verify the statistical significance of improvements in performance. Addi-
tionally, Table 5.5 shows that LULUPAPI formulation achieved 2.39% improvement
over the most competitive deep learning method.
Table 5.1: LUPAPI results for ARDS classification.
Train Test
Accuracy Sensitivity Specificity AUC Accuracy Sensitivity Specificity AUC
SVM 88.61 80.43 91.76 86.10 89.27 76.59 90.33 83.46
Vapnik’s Model 86.01 78.51 88.91 83.71 88.42 75.62 89.50 82.56
Mixture Model 88.09 81.28 90.72 86.00 88.78 82.23 89.34 85.78
Symmetric Mixture Model 88.56 81.59 91.26 86.42 88.94 81.13 89.60 85.37
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SVM 78.04 81.13 45.71 59.18
SVM+ 83.81 83.75 51.02 62.83
SVM w/ LU 81.57 85.48 52.85 64.50
DT 73.59 67.05 50.30 73.58
DT+ 77.30 72.44 64.91 88.47
SVM = support vector machine, SVM+ = LUPI implementation with support vector machine,
SVM w/ LU = support vector machine with label uncertainty, DT = decision tree,
DT+ = LUPI implementation with decision trees.
Table 5.2: ARDS classification results using SVM.
Train Test
Accuracy Sensitivity Specificity AUC Accuracy Sensitivity Specificity AUC F1 Score
SVM 88.61 80.43 91.76 86.10 89.27 76.58 90.33 83.46 79.73
SVM with LU 87.56 78.74 90.96 84.85 89.52 80.03 90.32 85.17 79.60
LUPAPI 88.09 81.28 90.72 86.00 88.78 82.23 89.34 85.78 79.17
LULUPAPI 87.96 83.59 89.65 86.62 88.38 85.40 88.63 87.01 79.46
The McNemar test [129] was employed to assess the statistical significance of
improvements in performance of the proposed models over SVM. Since this test is
insensitive to the proportion of positive versus negative cases [130], the test was
applied exclusively to positive cases. Table 5.3 summarizes the results of the McNemar
tests and verifies the statistical significance of incorporating both label uncertainty
and partial available privileged information in detection of patients with ARDS.
Table 5.3: McNemar X 2 test assessment of statistical significance of performance improve-
ments exclusively among ARDS patients.
SVM SVM w/ LU LUPAPI LULUPAPI
SVM 0 12.80 39.02 56.70
SVM w/ LU X 0 10.22 33.58
LUPAPI X X 0 15.61
LULUPAPI X X X 0
In this table, each row represents the null classifier, and each column represents the alternative
classifier. For example, LULUPAPI versus SVM has the MeNemar test statistic X 2 = 56.70,
which is extremely in favor of LULUPAPI (p-value  0.001), If the null classifier outperforms
the alternative classifier, the value is represented with an X.
Beyond comparisons with SVM-based methods, the LUPAPI and LULUPAPI
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Table 5.5: Comparison of ARDS classification using LUPAPI mixture model, LULUPAPI
mixture model, and deep learning methods.
Train Test
Accuracy Sensitivity Specificity AUC Accuracy Sensitivity Specificity AUC
LUPAPI 88.09 81.82 90.72 86.00 88.78 82.23 89.34 85.78
LULUPAPI 87.96 83.59 89.65 86.62 88.38 85.40 88.63 87.01
Shallow NN (2 layers, 10 nodes) 87.52 86.65 87.77 87.31 79.98 84.99 79.56 82.23
Shallow NN (2 layers, 50 nodes) 87.89 84.81 89.08 86.94 83.41 82.97 89.05 85.39
Shallow NN (2 layers, 100 nodes) 87.41 82.43 89.33 85.88 87.97 66.67 89.76 78.22
LSTM (25 layers, 10 nodes) 90.94 83.10 93.97 88.53 88.39 64.33 90.41 77.34
LSTM (25 layers, 50 nodes) 91.99 84.67 94.82 89.74 88.91 70.39 90.47 80.43
LSTM (25 layers, 100 nodes) 92.62 85.79 95.25 90.52 87.40 71.76 88.71 80.24
models were also benchmarked against multiple popular deep learning methods. A
“shallow” neural network (two-layer feedforward network) with one hidden layer of
either 10, 50, or 100 nodes was trained to create a less complex neural network more
suitable for this type of data. In addition, a long short-term memory (LSTM) network,
a specialized type of artificial recurrent neural network for time-series sequential data
[131], was also trained to provide a performance comparison to a state-of-the-art
deep learning algorithm. The LSTM network was composed of 25 layers with either
10, 50, or 100 hidden units. Both the shallow neural network (Shallow NN) and
LSTM models were implemented with the Keras deep learning library using the Adam
optimizer algorithm [132] with 500 epochs (mini-batch size of 32) and cross entropy
as the loss function. Table 5.5 summarizes the results of this experiment. As can be
seen, LUPAPI and LULUPAPI outperformed the deep learning methods.
5.4 Discussion
While Vapnik’s model (5.1) is a natural extension of the SVM+ framework, the ex-
periments showed that only the two SVMp+ models (5.5) and (5.8) outperform SVM
on the real-world ARDS dataset. Moreover, on the ARDS dataset, which contained
both partially available privileged information and label uncertainty, the LULUPAPI
model incorporating both outperformed the LUPAPI model that solely considered
privileged information. Even though these models were developed with clinical de-
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cision support systems in mind, the proposed models can be applied to many other
machine learning applications in healthcare and other domains.
Though the LUPAPI and LULUPAPI frameworks improved performance overall,
Vapnik’s model underperformed the mixture models and SVM on the ARDS dataset.
Based on the experiments, the primary reason for such performance is due to the
offset parameter b of the decision function (the detailed calculation of which can be
found in the Appendices). For the mixture models and SVM, the set N (defined in the
Appendices) includes fewer αis, corresponding to fewer support vectors that would be
used to calculate the offset parameter. This is in turn due to the consideration of slack
variables for all samples, regardless of privileged information availability. However,
for Vapnik’s model the set N consists of more αs that negatively effects the offset
parameter precision.
With respect to time complexity, the proposed alternating SMO-style algorithm
for the LUPAPI model is O(n). This is similar to the SMO algorithm for conventional
SVM and the alternating SMO algorithm for the LUPI model (the SVM+ formula-
tion), and results from the feasible direction vectors having a constant number of
nonzero components. However, the experiments showed that given the same parame-
ters and stoppage criterion, Vapnik’s model required more iterations for convergence.
The experimental results also support the claim that if the hyperparameter op-
timization is performed thoroughly, performance of the mixture model (9) is always
lower-bounded by SVM. This claim can also be verified using the dual forms, noting





In just the past decade, machine learning has made a profound impact in many
areas of science and technology, including life science and medical research. Ongoing
research and recent advances demonstrated the potential to transform the medical
landscape - from early diagnosis through clinical decision support to epidemiology,
drug development, and robotic-assisted surgery. These diverse efforts share the ulti-
mate goal of improving quality of care and outcome for patients.
In this thesis, I propose the integration of label uncertainty and learning using
privileged information to develop robust machine learning models for detection of
ARDS (§5.2.2). This research also includes development of methods for time-series
analysis of longitudinal health data (§2.2), signal processing techniques for quality
assessment (§2.3), lung segmentation from complex CXRs (§3.3.1), and novel feature
extraction algorithm for quantification of pulmonary opacification (§3.5.1). These
algorithms were tested and validated on retrospective study on data obtained from
hospitalized patients at Michigan Medicine in addition to data from external sources
(e.g. publicly available databases). These studies demonstrate that careful, principled
use of methodologies in machine learning and artificial intelligence can potentially
assist healthcare providers with early detection of ARDS. However, in light of these
advances, it is imperative to ensure that the developed methods are practical, reliable,
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clinical valid, and interpretable decision making tools.
Using AI in any existing research domain often heralds comparison to a (human)
expert’s performance for the same task. In research, if the domain expert achieves
90% accuracy for a given task and a machine learning model reports 95% on the same
test set - we can celebrate that advances were made and significant milestones have
been reached. However, if a CXR diagnosis model outperforms a panel of radiologists,
should that mean healthcare providers and hospital administrators can use it for their
patients? In reality, physicians and clinical experts care more about safety, reliability,
bias, performance on edge cases, and a number of other factors on which can’t assess
with a simple performance benchmark.
Although AI has potential to improve healthcare, the process of bringing these
advances to the practice seems to be the primary current setback to adoption and
innovation. For example - if you’ve put a neural network into production but achieved
slightly better results with a re-trained model, do you simply re-deploy the update
model for immediate use? In research, and also in certain commercial applications,
this is considered standard practice. However, in healthcare, if the updated model
misses an edge case, an incorrect medical decision may be made - possibly resulting
in an adverse outcome for the patient. This problem also poses significant challenges
for agencies like the U.S. Food and Drug Administration (FDA) who are used to
regulating products, not systems.
As such, there are is a growing need for a system view to regulate AI/ML-based
software as medical devices [133]. The FDA has recently released an action plan [134]
to address some of these issues. In this approach, they expressed an expectation for
transparency and real-world performance monitoring by manufacturers that could
enable FDA and manufacturers to evaluate and monitor a software product from its
pre-market development through post-market performance. These new safety chal-
lenges would enable FDA to provide a reasonable assurance of safety and effectiveness
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while embracing the iterative improvement power of artificial intelligence and machine
learning-based software as a medical device.
In addition to the action plan, the FDA also highlighted the importance of Good
Machine Learning Practice (GMLP) through consensus driven standards and other
community initiatives. They provide guidance similar to good software engineering
practices (e.g. data management, feature extraction, training, interpretability, eval-
uation, and documentation) in an effort to facilitate the shift in evaluation through
their proposed regulatory approach. Furthermore, to encourage transparency with
assessment and adoption, they also provide structured requirements for demonstra-
tion of analytical validation (e.g. performance evaluation protocols to minimize data
leakage if the data is used in multiple evaluations) and clinical validation (e.g. en-
suring that the software is valid on the targeted population in the context of clinical
care).
Although these regulatory processes can feel like additional obstacles and chal-
lenges to overcome, the updated guidelines should be seen as a starting point to
accelerate adoption and improve the quality of machine learning in healthcare. This
shift in perspective is crucial to maximizing the safety and efficacy of AI/ML in clin-
ical applications. These discussions at the regulatory level and advances in research,
like the works presented in this thesis, gives hope for the community to continue





Data Dictionary for Covariates Used as Features





sbp Systolic blood pressure
dbp Diastolic blood pressure
PEEP Positive end-expiratory pressure
plat Plateau pressure
mAirP Mean airway pressure
wbc White blood cell count level
lactate Lactate acid level obtained by blood gas
bicarb Bicarbonate level
paco2 Carbon dioxide level obtained by blood gas
pH pH level obtained by blood gas




invasive If patient is currently receiving invasive mechanical ventilation (1 = yes, 0 = no)
non invasive If patient is currently receiving non-invasive mechanical ventilation (1 = yes, 0 = no)
sp02 Pulse oximetry value
fi02 Level of supplemental oxygen (FiO2 = fraction of inspired oxygen)
pf Ratio of blood oxygen to supplemental oxygen (P/F = Pa02/FiO2)
pressor If patient is currently receiving vasopressor support for hemodynamic insufficiency
net in Net IV fluids: amount of total IV fluids given (total urinary output to date)
shock Ratio of heart rate over systolic blood pressure
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APPENDIX B
Additional Results for Directional Blur








Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 73.55 68.61 59.42 71.65 65.78 58.43 72.64 67.88 60.48 74.86 73.41 64.06
Random Forrest 75.67 66.58 59.44 73.67 65.45 55.12 74.77 65.67 59.63 76.76 71.59 63.34
AdaBoost 79.55 75.61 62.43 75.76 73.32 59.19 77.83 74.50 61.44 83.51 79.93 65.47
RUSBoost 77.53 73.48 62.11 75.67 72.48 61.33 76.70 72.35 63.41 81.93 77.80 67.56
Robust Boost 71.55 70.61 60.13 70.52 68.94 56.37 73.96 68.44 59.52 76.47 73.82 63.42
Total Boost 70.65 69.77 68.91 70.84 67.61 55.38 71.54 66.53 58.11 73.84 68.31 59.60








Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 74.55 69.60 62.71 72.56 63.32 58.55 72.62 67.55 62.47 74.56 73.27 64.05
Random Forrest 76.56 68.69 59.22 74.58 65.98 56.12 74.79 66.51 59.27 76.58 71.61 63.32
AdaBoost 81.53 77.80 63.51 76.63 74.91 59.36 77.51 75.81 61.32 83.87 79.50 65.49
RUSBoost 79.53 76.60 66.48 76.92 72.51 65.40 78.55 75.61 63.29 81.53 77.91 67.70
Robust Boost 70.51 70.70 60.39 71.90 69.32 57.60 74.55 71.53 57.10 76.59 73.90 63.44
Total Boost 71.53 69.90 58.44 70.53 66.31 55.09 72.31 70.22 55.31 73.57 68.43 59.55








Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1 Accuracy AUC F1
SVM 75.60 70.53 64.90 72.34 65.71 62.34 73.50 65.53 62.19 74.80 73.84 64.77
Random Forrest 76.71 67.95 62.30 74.59 66.91 59.04 74.61 66.10 63.37 76.88 71.30 63.43
AdaBoost 80.55 77.90 65.13 76.78 74.32 62.15 77.59 75.88 64.30 83.56 79.89 65.41
RUSBoost 80.76 76.51 65.19 75.65 72.94 61.34 78.55 75.61 65.04 81.82 77.89 67.55
Robust Boost 72.35 69.54 60.11 72.93 68.59 58.44 73.54 71.65 61.40 76.55 73.90 63.34




Let θ be a (n+m)-variable vector as the concatenation of the α and β variables: θ , (α, β)T .
Feasible Directions and the Clipping Function
It can be verified that the cost function in equation 5.2 has 9 sets of maximally sparse feasible
directions (defined in §5.2.3) as follows:
Direction 1: I1 , {us | s = (s1, s2) , n+ 1 ≤ s1, s2 ≤
n+m, s1 6= s2;us1 = 1, us2 = −1, θs2 > 0,∀i /∈ sui = 0}
Direction 2: I2 , {us | s = (s1, s2) , 1 ≤ s1, s2 ≤ m, s1 6=
s2, ys1 = ys2 ;us1 = 1, us2 = −1, θs2 > 0,∀i /∈ sui = 0}
Direction 3: I3 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤
n, s1 6= s2, ys1 = ys2 ;us1 = 1, θs1 < C, us2 = −1, θs2 >
0,∀i /∈ sui = 0} .
Direction 4: I4 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤
n, s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;us1 = us2 = 1, θs1 <
C, θs2 < C or us1 = us2 = −1, θs1 > 0, θs2 > 0}
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Direction 5: I5 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤
m,n+ 1 ≤ s3 ≤ n+m, s1 6= s2, ys1 6= ys2 ,∀i /∈ sui =
0;us1 = us2 = 1, us3 = −2, θs3 > 0 or us1 = us2 =
−1, θs1 > 0, θs2 > 0, us3 = 2}
Direction 6: I6 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤
m,m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 = ys2 ,∀i /∈
sui = 0;us1 = 1, us2 = −1, θs2 > 0, us3 = −1, θs3 >
0 or us1 = −1, θs1 > 0, us2 = 1, θs2 < C, us3 = 1}
Direction 7: I7 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,m+
1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 6= ys2 ,∀i /∈ sui =
0;us1 = us2 = 1, θs2 < C, us3 = −1, θs3 > 0 or us1 =
us2 = −1, θs1 > 0, θs2 > 0, us3 = 1}
Direction 8: I8 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤
m,m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys2 ,∀i /∈
sui = 0;us1 = 1, us2 = −1, θs2 > 0, us3 = 2, θs3 <
C or us1 = −1, θs1 > 0, us2 = 1, us3 = −2, θs3 > 0}
Direction 9: I9 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤
m,m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys1 ,∀i /∈
sui = 0;us1 = 1, us2 = −1, θs2 > 0, us3 = −2, θs3 >
0 or us1 = −1, θs1 > 0, us2 = 1, us3 = 2, θs3 < C}
Generally, a move from an old feasible point θold to a new feasible point θold = θold + λus
in the direction of us ∈ ∪Ii will satisfy all the constraints corresponding to the dual problem if the
step size λ fulfills the bounding constraints of equation 5.2. In §5.2.3 it was shown how the best
direction and the corresponding step size parameter λ are chosen. After determining the direction
and step size, the clipping function (C.1), ensures that the aforementioned boundary conditions of























Offset Parameter of the Decision Function
In order to calculate the offset parameter b of the decision function, suppose α and β are the
solution of the SVMp+ dual problem (2). Define the two sets N , {i |1 ≤ i ≤ m,αi〉 0} and
N ′ , {i | m+ 1 ≤ i ≤ n, 0 < αi < C} . By the conditions in SVMp+, for the support vectors the
KarushKuhn-Tucker (KKT) conditions state [128, 135]:
∀i ∈ N yi (w · zi + b) = 1− (w∗ · z∗i + b∗) (C.2)
∀i ∈ N ′ yi (w · zi + b) = 1 (C.3)
Define:





















j=1 (αj + βj − C∗)K∗ij
∣∣∣
i∈N
The equalities in equations C.2 and C.3 can be rewritten as:

b+ b∗ = 1− fiγ − Fi ∀i ∈ N, yi = 1
b− b∗ = −1 + fiγ − Fi ∀i ∈ N, yi = −1
b = 1− F ′i ∀i ∈ N ′, yi = 1
b = −1− F ′i ∀i ∈ N ′, yi = −1




1− fiγ − Fi
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−1 + fiγ − Fi
)
, N ′+ = {i | i ∈ N ′, yi = 1} and S′+ =
∑
i∈N ′+
(1− F ′i ) , N ′− =
{i | i ∈ N ′, yi = −1} and S′− =
∑
i∈N ′−
(−1− F ′i ) . Solving the four equations gives two possible
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Let θ be a (n+m)-variable vector as the concatenation of the α and β variables: θ , (α, β)T .
Feasible Directions and the Clipping Function
For the cost function in equation (5.6) and its constraints, the sets of feasible directions are as
follows:
Direction 1: I1 , {us | s = (s1, s2) , n+ 1 ≤ s1, s2 ≤
n+m, s1 6= s2;us1 = 1, us2 = −1, θs2 > 0,∀i /∈ sui = 0} .
Direction 2: I2 , {us | s = (s1, s2) , 1 ≤ s1, s2 ≤ m, s1 6=
s2, ys1 = ys2 ;us1 = 1, θs1 < ρC
∗, us2 = −1, θs2 > 0,∀i /∈
sui = 0} .
Direction 3: I3 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 = ys2 ;us1 = 1, θs1 < C, us2 = −1, θs2 > 0,
∀i /∈ sui = 0} .
Direction 4: I4 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;us1 = us2 = 1, θs1 < C,
θs2 < C or us1 = us2 = −1, θs1 > 0, θs2 > 0} .
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Direction 5: I5 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
n+ 1 ≤ s3 ≤ n+m, s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;
us1 = us2 = 1, θs1 < ρC
∗, θs2 < ρC
∗, us3 = −2, θs3 > 0
or us1 = us2 = −1, θs1 > 0, θs2 > 0, us3 = 2} .
Direction 6: I6 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 = ys2 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗, us2 = −1, θs2 > 0, us3 = −1, θs3 > 0
or us1 = −1, θs1 > 0, us2 = 1, θs2 < C, us3 = 1} .
Direction 7: I7 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 6= ys2 ,∀i /∈ sui = 0;
us1 = us2 = 1, θs1 < ρC
∗, θs2 < C, us3 = −1, θs3 > 0
or us1 = us2 = −1, θs1 > 0, θs2 > 0, us3 = 1} .
Direction 8: I8 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys2 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗, us2 = −1, θs2 > 0, us3 = 2, θs3 < C
or us1 = −1, θs1 > 0, us2 = 1, θs2 < ρC∗, us3 = −2, θs3 > 0}.
Direction 9: I9 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys1 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗, us2 = −1, θs2 > 0, us3 = −2, θs3 > 0
or us1 = −1, θs1 > 0, us2 = 1, θs2 < ρC∗, us3 = 2, θs3 < C}.
It can be verified that when moving from any feasible point θold in the direction of us ∈ ∪Ii
and applying the clipping function of equation (30), the constraints corresponding to dual problems
are satisfied.
Offset Parameter of the Decision Function
In order to calculate the offset parameter b of the decision function, suppose α and β are the
solution of the SVMp+ dual problem (10). Define the two sets N , {i | 1 ≤ i ≤ m, 0 < αi < ρC∗}
and N ′ ,
{
i | m+ 1 ≤ i ≤ n, 0 < ᾱi < C
}
.




Let θ be a (n+m)-variable vector as the concatenation of the α and β variables: θ , (α, β)T .
Feasible Directions and the Clipping Function
Using the cost function in equation (5.9), the sets of feasible directions are:
Direction 1: I1 , {us | s = (s1, s2) , n+ 1 ≤ s1, s2 ≤
n+m, s1 6= s2, ys1−n = ys2−n;us1 = 1, us2 = −1, θs2 > 0,
∀i /∈ sui = 0} .
Direction 2: I2 , {us | s = (s1, s2) , n+ 1 ≤ s1, s2 ≤
n+m, s1 6= s2, ys1−n 6= ys2−n,∀i /∈ sui = 0;us1 = us2 = 1
or us1 = us2 = −1, θs1 > 0, θs2 > 0} .
Direction 3: I3 , {us | s = (s1, s2) , 1 ≤ s1, s2 ≤ m,
s1 6= s2, ys1 = ys2 ;us1 = 1, θs1 < ρC∗, us2 = −1, θs2 > 0,
∀i /∈ sui = 0} .
Direction 4: I4 , {us | s = (s1, s2) , 1 ≤ s1, s2 ≤ m,
s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;us1 = us2 = 1, θs1 < ρC∗,
θs2 < ρC
∗ or us1 = us2 = −1, θs1 > 0, θs2 > 0}
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Direction 5: I5 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 = ys2 ;us1 = 1, θs1 < C, us2 = −1, θs2 > 0,
∀i /∈ sui = 0} .
Direction 6: I6 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;us1 = us2 = 1, θs1 < C,
θs2 < C or us1 = us2 = −1, θs1 > 0, θs2 > 0} .
Direction 7: I7 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 = ys2 = ys3 − n,
∀i /∈ sui = 0;us1 = −1, θs1 > 0, us2 = 1, θs2 < C, us3 = 1
or us1 = 1, θs1 < ρC
∗, us2 = −1, θs2 > 0, us3 = −1, θs3 > 0}.
Direction 8: I8 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 = ys2 , ys3−n 6= ys1 ,
∀i /∈ sui = 0;us1 = −1, θs1 > 0, us2 = 1, θs2 < C,
us3 = −1, θs3 > 0 or us1 = 1, θs1 < ρC∗, us2 = −1,
θs2 > 0, us3 = 1} .
Direction 9: I9 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 6= ys2 , ys3−n = ys1 ,
∀i /∈ sui = 0;us1 = 1, θs1 < ρC∗, us2 = 1, θs2 < C,
us3 = −1, θs3 > 0 or us1 = −1, θs1 > 0, us2 = −1,
θs2 > 0, us3 = 1} .
Direction 10: I10 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 6= ys2 , ys3−n = ys2 ,
∀i /∈ s ui = 0;us1 = 1, θs1 < ρC∗, us2 = 1, θs2 < C, us3 = 1
or us1 = −1, θs1 > 0, us2 = −1, θs2 > 0, us3 = −1, θs3 > 0}.
As described in the Chapter V, after determining the best feasible direction and the correspond-
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(E.1)
Offset Parameter of the Decision Function
If equation (5.9) is considered, the two sets N , {i | 1 ≤ i ≤ m, 0 < αi < ρC∗} and N ′ ,
{i | m+ 1 ≤ i ≤ n, 0 < αi < C} are defined. By the conditions for equation (5.8), for the support
vectors, the KKT conditions state:
∀i ∈ N yi (w · zi + b) = 1− yi (w∗ · z∗i + b∗)
∀i ∈ N ′ yi (w · zi + b) = 1
Define (note that fi is not the same as the previous cases in Appendices C and D):
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Note that not only is fi not the same as previous cases, but the second equation has also been
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N ′+ = {i | i ∈ N ′, yi = 1} and S′+ =
∑
i∈N ′+
(1− F ′i ) N ′− =
{i | i ∈ N ′, yi = −1} and S′− =
∑
i∈N ′−
(−1− F ′i ) Solving the four equations gives two possible
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Let θ be a (n+m) -variable vector as the concatenation of the α and β variables: θ , (α, β)T .
Feasible Directions and the Clipping Function
For the cost function in equation (5.11) and its constraints, the sets of feasible directions are as
follows:
Direction 1: I1 , {us | s = (s1, s2) , n+ 1 ≤ s1,
s2 ≤ n+m, s1 6= s2;us1 = 1, us2 = −1, θs2 > 0,∀i /∈ sui = 0} .
Direction 2: I2 , {us | s = (s1, s2) , 1 ≤ s1, s2 ≤ m, s1 6= s2,
ys1 = ys2 ;us1 = 1, θs1 < ρC
∗πs1 , us2 = −1, θs2 > 0,∀i /∈ sui = 0}.
Direction 3: I3 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 = ys2 ;us1 = 1, θs1 < Cπs1 , us2 = −1, θs2 > 0,∀i /∈ sui = 0}.
Direction 4: I4 , {us | s = (s1, s2) ,m+ 1 ≤ s1, s2 ≤ n,
s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;us1 = us2 = 1, θs1 < Cπs1 ,
θs2 < Cπs2 or us1 = us2 = −1, θs1 > 0, θs2 > 0} .
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Direction 5: I5 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
n+ 1 ≤ s3 ≤ n+m, s1 6= s2, ys1 6= ys2 ,∀i /∈ sui = 0;
us1 = us2 = 1, θs1 < ρC
∗πs1 , θs2 < ρC
∗πs2 , us3 = −2,
θs3 > 0 or us1 = us2 = −1, θs1 > 0, θs2 > 0, us3 = 2}
Direction 6: I6 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 = ys2 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗πs1 , us2 = −1, θs2 > 0, us3 = −1,
θs3 > 0 or us1 = −1, θs1 > 0, us2 = 1, θs2 < Cπs2 , us3 = 1}.
Direction 7: I7 , {us | s = (s1, s2, s3) , 1 ≤ s1 ≤ m,
m+ 1 ≤ s2 ≤ n, n+ 1 ≤ s3 ≤ n+m, ys1 6= ys2 ,∀i /∈
sui = 0;us1 = us2 = 1, θs1 < ρC
∗πs1 , θs2 < Cπs2 , us3 = −1,
θs3 > 0 or us1 = us2 = −1, θs1 > 0, θs2 > 0, us3 = 1}.
Direction 8: I8 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys2 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗πs1 , us2 = −1, θs2 > 0, us3 = 2, θs3 < Cπs3
or us1 = −1, θs1 > 0, us2 = 1, θs2 < ρC∗πs2 , us3 = −2, θs3 > 0}.
Direction 9: I9 , {us | s = (s1, s2, s3) , 1 ≤ s1, s2 ≤ m,
m+ 1 ≤ s3 ≤ n, s1 6= s2, ys1 6= ys2 , ys3 = ys1 ,∀i /∈ sui = 0;
us1 = 1, θs1 < ρC
∗πs1 , us2 = −1, θs2 > 0, us3 = −2, θs3 > 0
or us1 = −1, θs1 > 0, us2 = 1, θs2 < ρC∗πs2 , us3 = 2, θs3 < Cπs3}.
It can be verified that when moving from any feasible point θold in the direction of us ∈ ∪Ii and


































∣∣∣∣)} m+ 1 ≤ k ≤ n, k ∈ s∗(i), uk > 0
(F.1)
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Offset Parameter of the Decision Function
In order to calculate the offset parameter b of the decision function, suppose α and β are the
solution of the SVMp+ dual problem (23). Define two sets N , {i | 1 ≤ i ≤ m, 0 < αi < ρπiC∗} and
N ′ , {i | m+ 1 ≤ i ≤ n, 0 < αi < Cπi} The rest of the calculations are then similar to the previous
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[118] Ulaş Bağcı, Mike Bray, Jesus Caban, Jianhua Yao, and Daniel J Mollura. Computer-assisted
detection of infectious lung diseases: a review. Computerized Medical Imaging and Graphics,
36(1):72–84, 2012.
[119] Shigehiko Katsuragawa and Kunio Doi. Computer-aided diagnosis in chest radiography. Com-
puterized Medical Imaging and Graphics, 31(4-5):212–223, 2007.
[120] Vladimir Vapnik and Akshay Vashist. A new learning paradigm: Learning using privileged
information. Neural networks, 22(5-6):544–557, 2009.
145
[121] Vladimir Vapnik and Rauf Izmailov. Learning using privileged information: similarity control
and knowledge transfer. J. Mach. Learn. Res., 16(1):2023–2049, 2015.
[122] Viktoriia Sharmanska, Novi Quadrianto, and Christoph H Lampert. Learning to rank using
privileged information. In Proceedings of the IEEE international conference on computer
vision, pages 825–832, 2013.
[123] Bernardete Ribeiro, Catarina Silva, Ning Chen, Armando Vieira, and Joao Carvalho das Neves.
Enhanced default risk models with svm+. Expert Systems with Applications, 39(11):10140–
10152, 2012.
[124] Lichen Liang and Vladimir Cherkassky. Connection between svm+ and multi-task learning.
In 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on
Computational Intelligence), pages 2048–2054. IEEE, 2008.
[125] Xue Li, Bo Du, Yipeng Zhang, Chang Xu, and Dacheng Tao. Iterative privileged learning.
IEEE transactions on neural networks and learning systems, 31(8):2805–2817, 2019.
[126] John Platt. Sequential minimal optimization: A fast algorithm for training support vector
machines. 1998.
[127] Dmitry Pechyony, Rauf Izmailov, Akshay Vashist, and Vladimir Vapnik. Smo-style algorithms
for learning using privileged information. In Dmin, pages 235–241, 2010.
[128] Dmitry Pechyony and Vladimir Vapnik. Fast optimization algorithms for solving svm+. Stat.
Learning and Data Science, 1, 2011.
[129] Thomas G Dietterich. Approximate statistical tests for comparing supervised classification
learning algorithms. Neural computation, 10(7):1895–1923, 1998.
[130] A Trajman and RR Luiz. Mcnemar χ2 test revisited: comparing sensitivity and specificity
of diagnostic examinations. Scandinavian journal of clinical and laboratory investigation,
68(1):77–80, 2008.
[131] Sepp Hochreiter and Jürgen Schmidhuber. Long short-term memory. Neural computation,
9(8):1735–1780, 1997.
[132] Diederik P Kingma and Jimmy Ba. Adam: A method for stochastic optimization. arXiv
preprint arXiv:1412.6980, 2014.
[133] Sara Gerke, Boris Babic, Theodoros Evgeniou, and I Glenn Cohen. The need for a system
view to regulate artificial intelligence/machine learning-based software as medical device. NPJ
digital medicine, 3(1):1–4, 2020.
[134] U.S. Food & Drug Admisntration. Artificial intelligence and machine learning in software as a
medical device. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-
intelligence-and-machine-learning-software-medical-device, 2021.
[135] Stephen Boyd, Stephen P Boyd, and Lieven Vandenberghe. Convex optimization. Cambridge
university press, 2004.
146
